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ABSTRACT 
Merging the ability of cationic gold(I) catalysts to activate unsaturated π-systems with the 
electrophiles driven ring-opening reactions of furans, we describe a new approach to 2-spiroindolin-
3-ones from 4H-furo[3,2-b]indoles. The reaction occurs through a cascade sequence involving 
addition of a gold-activated allene to the furan moiety of the starting furoindole followed by a ring-
opening/ring-closing event affording 2-spirocyclopentane-1,2-dihydro-3H-indolin-3-ones in 
moderate to good yields. 
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INTRODUCTION 
2-Spirocyclopentane-1,2-dihydro-3H-indol-3-ones (namely, spiropseudo-indoxyls) have been widely 
reported in the literature as core components of several indole alkaloids, such as aristotelone and 
brevianamide A, possessing interesting biological properties (Figure 1A).1 More recently, the 
spiropseudo-indoxyl structure has been included in several simple molecules applicable as functional 
2 
 
fluorescent dyes2 (Figure 1B) and identified as an intermediate useful for the chemical synthesis of 
minfiensine (Figure 1C).3 
 
Figure 1. Representative spiropseudo-indoxyls: A natural compounds, B materials, C synthetic 
intermediate. 
 
The most commonly applied methodology for the synthesis of the natural derivatives involves 
consecutive hydroxylation of tetrahydrocarbazoles followed by acid or base catalyzed semipinacol 
rearrangement of the corresponding α-hydroxyimine (Scheme 1a).4 Over the years, the oxidation 
reaction conditions evolved from the use of m-CPBA5 and molecular oxygen6 to the use of 
biocatalytic transformations,7 N-sulfonyloxaziridine-type oxidants8 and photocatalytic aerobic 
oxidations.9 Moreover, a powerful organocatalytic approach for the rearrangement step has been 
recently reported.10 However, alternative synthetic strategies for the synthesis of spiropseudo-
indoxyls are limited to an interrupted Ugi reaction between imines and isocyanides11 (Scheme 1a) 
and to an enantioselective [3+2] annulation of α,β-unsaturated aldehydes with azaaurones (Scheme 
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1a).12 Furthermore, it is well recognized that ring opening reactions of furans allow for the installation 
of carbonyl functionalities often in a plain and selective manner (Scheme 1b).13 Mostly, these 
reactions occur through a dearomatization step followed by a ring-opening event. Dearomatization 
can take advantage from the intra- or intermolecular addition of a suitable activated partner at C2 
even if this position is already substituted. 
 
Scheme 1. Reported syntheses of spirospeudo-indolyls (a) and ring opening reactions of furans (b) 
 
Examples of this chemistry can be found in the intramolecular tropylium ion-mediated synthesis of 
naphth[1,2-a]azulenes,13c in the palladium-catalyzed route to ,-unsaturated aldehydes,13d and in the 
intramolecular addition of imines,13e azides13f or -arylpalladium complexes13g for the synthesis of 
2,3-disubstituted indoles. Moreover, [4+2]13h and [5+2]13i formal annulations/ring-opening reactions 
at C2-C3 of the furan ring afford carbonyl substituted isosaxoles or pyrazoles and aryl enones, 
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respectively. Taking into account these premises and our expertise in gold catalyzed reactions of 2-
vinyl-indoles14 and in gold catalyzed cascade reactions for the functionalization of the indole 
nucleus,15 we planned to test the reactivity of 4H-furo[3,2-b]indoles in the presence of electrophilic 
gold(I) activate π-systems (allenamides) with the aim to develop a new cascade process encompassing 
functionalization at the furan moiety, possibly followed by a ring-opening/ring-closing event 
(Scheme 2). Gold(I) activated C3 unsubstituted allenamides react with nucleophilic partners 
(electron-rich arenes and heteroarenes) at the terminal carbon giving rise regioselectively to 
hydroarylated (enamide) derivatives.16 In this paper we report a full account of the obtained results.  
 
Scheme 2. Aim of our work 
 
RESULTS AND DISCUSSION 
There are only few reports on the synthesis of 4H-furo[3,2-b]indoles and, moreover, their reactivity 
is limited to simple N- or C2-functionalization reactions.17 Therefore, we started our investigations 
with the synthesis of a small set of 4H-furo[3,2-b]indole-4-carboxylates (1a-k, Scheme 3). 
Compounds 1a-j, bearing a hydrogen or a methyl group at C2, were synthesized in a four steps 
procedure by adaptation of reported methodologies (Scheme 3).17 In the last step, N-4 was protected 
as carbamate in order to avoid the formation of undesired hydroamination side products in the reaction 
with activated allenamides.16b,d C2-Ph derivative 1k was prepared from 1a via bromination followed 
by Suzuki-Miyaura coupling with phenyl boronic acid. N-allenamides 2a-g, employed in this work, 
are known compounds and were prepared according to literature procedures.18 
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Scheme 3. Synthesis of starting 4H-furo[3,2-b]indole-4-carboxylates 1a-k 
 
At the outset, furoindoles 1a and 1b were chosen as model compounds for the reactions with 
allenamide 2a in the presence of preformed cationic complex [Au(JohnPhos)NTf2] (Scheme 4). The 
reactions resulted in the isolation, in low yields, of simple hydroarylation product 3a with furoindole 
1a and of 2-spirocyclopentane-indolin-3-one 4a with furoindole 1b. 
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Scheme 4. Gold-catalyzed reactions of furoindoles 1a-b with allene 2a: initial findings 
 
Formation of compound 3a was quite disappointing, although predictable. Instead, the formation of 
the spiro compound 4a was remarkable as it involves the formation in a single step of a highly 
substituted 2-spiroindolin-3-one. The structures and the geometries around the double bonds of 
compounds 3a and 4a were assigned based on analytical and spectroscopic data and unambiguously 
confirmed by X-ray diffraction analysis of a single crystal (Figure 2). 
 
Figure 2. Left: ORTEPIII plot of compound 3a showing the numbering schemes for all non-hydrogen 
atoms. Ellipsoids drawn at 50% probability. Right: ORTEPIII plot of compound 4a showing the 
numbering schemes for all non-hydrogen atoms. Ellipsoids drawn at 50% probability. Only one of 
the two crystallographically independent, but conformationally equivalent molecules, is shown. 
7 
 
 
Therefore, we decided to look for the best reaction conditions for the synthesis of 4a using 1b and 2a 
as model compounds (Scheme 4 and Table 1). 
 
Table 1. Optimization of reaction conditions for the synthesis of 4a 
Entry 1b/2a Catalyst, (5 mol%) Solvent, [M] T, °C Time, min 4a[a], Yield% 
1 1/1.2 [Au(JohnPhos)NTf2] DCM, 0.05 M - 20 60 35% 
2 1/1 [(ArO)3PAu(NTf)2] DCM, 0.05 M - 20 60 32% 
3 1/1 [Au(IPr)NTf2] DCM, 0.05 M - 20 180 57% 
4 1/1 [Au(IPr)NTf2] Toluene, 0.05 M - 20 180 n.r.b 
5 1/1.2 [Au(IPr)NTf2] DCM, 0.05 M - 20 60 68% 
6 1/1.2 [Au(IPr)SbF6] DCM, 0.05 M - 20 60 63% 
7 1/1.2 HNTF2 (20 mol%) DCM, 0.05 M - 20 60 n.r.c 
8 1/1.5 [Rh(cod)Cl]2 DCM, 0.05 M - 20 24 n.r.c 
9 1/1.5 PtCl2 DCM, 0.05 M - 20 24 n.r.c 
All reactions were carried out using 1a (0.2 mmol) and 2a (0.2-0.24 mmol) in the stated solvent (0.05 
M). a Isolated yield. b Complex mixture of unidentified products was observed besides starting 
materials. c Starting 1b (and 2a) was (were) recovered unreacted at the end of the reaction (see text). 
Ar = 2,4-di-t-butylphenyl 
IPr = Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene] 
JohnPhos = (2-Biphenyl)di-tert-butylphosphine 
 
Starting from the preliminary results obtained with [Au(JohnPhos)NTf2] (Scheme 4 and Table 1, 
entry 1), we observed that the use of 5 mol% of [(ArO)3PAu(NTf)2] as catalyst did not produce any 
particular improvement in the yield (entry 2), while better results were obtained when [Au(IPr)NTf2] 
was selected as reaction catalyst (entry 3). Therefore, the employment of a N-heterocyclic carbene-
based gold(I) catalyst allowed for the isolation of 4a in 57% after 3 hours. Varying the reaction 
medium from dichloromethane to toluene had a negative effect on the reaction outcome, since led to 
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complete degradation of starting materials without formation of the desired product (entry 4). 
Meanwhile, the use of a slight excess of N-allenamide 2a led to improved 68% yield in shorter 
reaction time (entry 5). Finally, we checked the activity of [Au(IPr)SbF6] in order to verify if the gold 
counterion could have any influence in the formation of the product (entry 6). However, 4a was 
isolated in very similar 63% yield. In order to exclude an acid catalyzed process for the formation of 
4a we verified the activity of HNTf2 under standard conditions. However, no product was identified 
besides unreacted 1b (entry 7). Finally, the performances in this reaction of Rh(I)19 and Pt(II)20 
catalysts were tested, (entries 8, 9) with no results. Indeed, both 1b and 2a were recovered unreacted 
at the end of the reactions. 
Beside, we developed a catalytic system for the selective synthesis of 3a, which is an unknown 
compound, obtained in the model reaction from 1b and 2a as single E-isomer (Scheme 4 and Table 
2). 
 
Table 2. Optimization of reaction conditions for the synthesis of 3a 
Entry 1b/2a [Au] Solvent, [M] T, °C Time, min 3aa, Yield% 
1 1/1.2 [Au(JohnPhos)NTf2] DCM, 0.05 M - 20 60 15%
 
2 1/1.2 [Au(IPr)NTf2] DCM, 0.05 M - 20 60 n.r.
b 
3 1/1 [(ArO)3PAuNTf2] DCM, 0.05 M - 20 60 75% 
4 1.2/1 [(ArO)3PAuNTf2] 
DCM, 0.05 M 
4 Å MS 
- 20 30 81% 
5 1.2/1 [(ArO)3PAuNTf2] 
Toluene, 0.05 M 
4 Å MS 
- 20 15 90% 
6 1.2/1 HNTf2 (20 mol%) 
Toluene, 0.05 M 
4 Å MS 
- 20 15 n.r.b 
All reactions were carried out using 1a (0.2-0.24 mmol) and 2a (0.2-0.24 mmol) in the stated solvent (0.05 M). a 
Isolated yield. b Complex mixture of unidentified products was observed besides starting materials. 
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Ar = 2,4-di-t-butylphenyl. 
IPr = Chloro[1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene]. 
JohnPhos = (2-Biphenyl)di-tert-butylphosphine. 
 
In the first attempt, 3a was obtained in poor 15% yield (Scheme 4 and Table 2, entry 1). Moreover, 
applying the best reaction conditions for the synthesis of 4a, worse results were obtained (entry 2). 
Therefore, we observed that the formation of 3a from 1a was promoted by the use of an electrophilic 
triarylphosphite-based gold(I) catalyst, that yielded 3a in 75% as single E isomer (entry 3). Final 
optimization of the reaction conditions was achieved using 4Å molecular sieves in the presence of a 
slight excess of furoindole 1a (entry 4) and switching to toluene as solvent (entry 5). Under these 
optimized reaction conditions, 3a was obtained in excellent 90% yield. Also in this case an acid-
promoted process could be excluded (entry 6). With the optimized reaction conditions in hand, we 
first evaluated the reaction scope for the synthesis of 2-spirocyclopentane-indol-3-ones 4 considering 
the novelty of the transformation and the structure of the obtained compounds (Scheme 5).  
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a Reaction conditions: 1 (0.2 mmol), 2 (0.24 mmol), [Au(IPr)NTf2] (5 mol%) in CH2Cl2 (0.05 M), -20 °C, 1-18 h. Isolated 
yields. b 1.5 eq. of 2 were used. c 2.0 eq. of 2 were used. d Slow addition. 
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IPr = 1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene. 
 
Scheme 5. Synthetized 2-spirocyclopentane-indol-3-ones 4a-m.a 
At the outset, we tested the reactivity of 1a with different allenamides 2a-f. The reaction proceeded 
with moderate yield when pyrrolidone N-allenamide 2b was employed, affording 4b in 61% yield. 
Other N-allenamides, bearing an electronwithdrawing tosyl group at nitrogen, were also tested. In the 
case of N,4-dimethyl-N-(2λ5-propa-1,2-dien-1-yl)benzenesulfonamide (2c), we were able to isolate 
the corresponding product 4c in satisfactory 77% yield, while the reaction with the corresponding N-
phenyl substituted N-allenamide 2d was less effective and product 4d was isolated in 49% yield 
together with unreacted indole and unidentified side-products. N-benzylated allenamides were also 
employed. In particular N-benzyl-N-tosyl allenamide 2e reacted with 1b affording 4e in 62% yield, 
while the modification of the electronwithdrawing group from tosyl to t-butoxycarbonyl (Boc, allene 
2f) led to the formation of 4f in 72% yield. The use of furoindoles other than 1b was next evaluated. 
Thus, the reaction scope with furoindoles 1c-e, 1h-j was evaluated using oxazolidinone- and N-tosyl-
N-benzyl allenamides 2a and 2e, being the latter more reactive than the former. In particular, ethyl 
2,7-dimethyl-4H-furo[3,2-b]indole-4-carboxylate 1c, bearing a weak ED group at C7, smoothly 
reacted with allenamides 2a and 2e, giving the corresponding products 4g and 4h in 56% and 60% 
yield , respectively. Moreover, a similar behavior was observed with furoindole 1e, bearing a stronger 
ED methoxy group at C7, giving rise with allenamide 2a to spiroindolinone 4i in moderate 44% yield. 
However, when the same substituent was shifted from C7 to C6 on the starting furoindole (1i), both 
reactions with allenamides 2a and 2e failed. The influence of EWD groups was next tested. Thus, 
furoindole 1d bearing at C7 a fluorine atom did not react with allenamide 2a, whereas in the presence 
of allenamide 2e, spiroindole 4j was isolated in moderate 45%. Moving the fluorine atom from C7 to 
C6 on the starting furoindole (1h), we observed an increase in the reactivity and the reactions with 
both allenamides 2a and 2e afforded the corresponding spiroindolinones 4k and 4l in 52 and 65% 
yield. These results demonstrated that substituents with opposite EWD/ED properties exert opposite 
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effects on the reaction outcome and on the reactivity of C2 towards electrophilic reagents. 
Unfortunately, the presence of a strong EWD group such as a trifluoromethyl group on the starting 
furoindole (1j) totally inhibits the reactivity towards both allenamides 2a and 2e. Moreover, any 
attempt to react C2 phenyl substituted furoindole 1k with allenamides failed and starting materials 
were recovered unreacted even after prolonged reaction time at room temperature. Finally, furoindole 
1a was tested in the reaction with enantiopure allenamide 2g bearing a benzyl group on the 
oxazolidinone moiety ((R)-4-benzyl-3-(propa-1,2-dien-1-yl)oxazolidin-2-one). The reaction resulted 
in the isolation of 4m as a pair of diastereoisomers (13:1) in 49% yield. The structure of the prevailing 
compound 4m was demonstrated via mono and bidimensional NMR analyses.  
Subsequently, we briefly explored the scope for the synthesis of 2-amidoallyl-4H-furo[3,2-b]indoles 
3 (Scheme 6). 
 
aReaction conditions: 1 (0.24 mmol), 2 (0.2 mmol), [(ArO)3PAuNTf2] (5 mol%) in toluene (0.05 M), 4 Å MS, -20 °C, 
15 min. Isolated yields. Ar = 2,4-di-t-butylbenzene.  
 
Scheme 6. Synthesized 2-amidoallyl-4H-furo[3,2-b]indoles 3a-f.a 
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In this case, pyrrolidone-derived N-allenamide 2b led to the formation of 3b in 80% yield, while 
hydroarylated derivatives 3c and 3d were efficiently obtained by the employment of N-tosylated N-
allenamides 2c and 2d. We also extended the scope to different 4H-furo[3,2-b]indoles bearing a 
methyl group or a fluorine atom in 7-position with 2a. These modifications were well tolerated and 
compound 3e and 3f were isolated in 70% and 95% yield, respectively. 
Then, we planned to carry out some simple synthetic elaborations on the obtained spiro-compounds 
4, scheme 7. Compounds 4 demonstrated to be stable under both chemical (NaBH4, LiAlH4) and 
catalytic reductive conditions (H2 - Pd/C; H2 - Pt2O). The same was observed under basic hydrolytic 
conditions. However, treatment of 4f and 4h with trifluoroacetic acid followed by basic work-up, 
resulted in the isolation of ammonium salts 5a and 5b albeit in poor yields beside a series of 
unidentified by-products. Finally, under oxidative conditions (Se2O) we were able to isolate 
compound 6 resulting from an extensive oxidation process in 25% yield. Also in this reaction the 
main compound was accompanied by several unidentified by-products. 
 
Scheme 7. Synthetic elaborations of compounds 4 
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Finally, we believe that the reaction occurs in both cases through the activation of the N-allenamide 
by means of the cationic gold(I) species (Scheme 8, intermediate I), followed by nucleophilic addition 
of the C-2 furan. Next, when R = H (1a) the reaction proceeds by a well-known hydroarylation 
mechanism16 via proton elimination and cleavage of the gold-carbon bond by the proton generated in 
the previous step (protodeauration), delivering furoindole 3 (path A). When R = Me (1b), intermediate 
II cannot re-aromatize and undergoes a rearrangement involving a furan ring opening event13 with 
formation of iminium indole derivative III. Subsequently, cyclization of III may be initiated by 
enaminone system providing intermediate IV or assisted by gold via an electrostatic interaction with 
indole C2 resulting in the pseudo-metallacyclic intermediate V. In both cases, elimination of gold(I) 
affords the final reaction product 4 (path B). 
The allene is activated by coordination 
to cationic gold and undergoes electrophilic aromatic substitution with the electron-rich arene to give 
vinyl-gold 
complex B, which is deprotonated to produce the neutral 
vinyl-gold intermediate C. Cleavage of the gold-carbon bond by the proton generated in the previous 
step affords 2 
and regenerates the cationic gold catalyst 
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Scheme 8. Proposed reaction mechanism 
Although we have no evidences of the subsistence of intermediates IV and V we believe, in 
accordance with several authors,20,21 that an intermediate like V better explains the stereochemistry 
of the obtained products. The role of allenamides in these reactions could be related to the formation 
of stabilized reaction intermediates upon activation by gold, see intermediate I in scheme 8.20, 22 
 
CONCLUSIONS 
In summary, we designed a novel strategy for the synthesis of indolin-3-one derivatives. The idea 
was to bring together the ring opening reactions of furan derivatives, promoted by electrophiles, with 
the construction of indolin-3-one scaffolds in which the carbonyl group arises from the ring opening 
reaction of the furan ring condensed with the starting indole skeleton. The chosen electrophiles are 
gold(I) activated allenamides which react with 2-methyl-4H-furo[3,2-b]indoles in a cascade reaction 
involving C2 hydroarylation, furan ring opening and intramolecular spirocyclisation giving rise to 2-
spiroindolin-3-ones in moderate to good yields. Moreover, variation of the electronic properties of 
furoindoles revealed an interesting mechanism of modulation for the reactivity at C2. The limit of 
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this approach resides in the need to operate with C2 substituted furoindoles in order to avoid the 
competitive hydroarylation and rearomatisation sequence. Furthermore, only C2 alkyl-substituted 
furoindoles participate in these reactions and the reaction performed with C2 phenyl-substituted 
furoindole failed to give the expected compound. Despite that, we believe we have shaped the right 
conditions for the growth of a new synthetic concept that, if properly developed, could give rise to 
diverse and nice results. Thus, switching to different electrophiles or involving the C2-C3 bond in 
addition/annulation reactions followed by new rearrangements will be the subject of our next 
investigations. 
 
EXPERIMENTAL SECTION 
All chemicals and solvents are commercially available and were used after distillation or treatment 
with drying agents. Silica gel F254 thin-layer plates were employed for thin-layer chromatography 
(TLC). Silica gel 40-63 micron/60 Å was employed for flash column chromatography. Melting points 
were measured with a Perkin- Elmer DSC 6 calorimeter at a heating rate of 5 °C/min and are 
uncorrected. 1H and 13C NMR spectra were determined with a Varian-Gemini 300, Bruker 300, 
Bruker 500 or Bruker 600 spectrometers at room temperature in CDCl3, CD2Cl2 or C6H6 with residual 
solvent peaks as the internal reference. The APT sequences were used to distinguish the methine and 
methyl carbon signals from those arising from methylene and quaternary carbon atoms. Two-
dimensional NMR experiments were performed, where appropriate, to aid the assignment of 
structures. Low-resolution MS spectra were recorded with a Thermo-Finnigan LCQ advantage AP 
electrospray/ion trap equipped instrument using a syringe pump device to directly inject sample 
solutions. Slow additions were performed using NE-1000 Programmable Single Syringe Pump of the 
New Era Pump Systems Inc. N-allenamides 2a-g are known compounds and were prepared according 
to literature procedures.18 PPh3PAuCl, AuCl3, AgNTf2 and AgSbF6 were purchased from commercial 
suppliers and used as received, while the rest of the gold catalysts were prepared following literature 
procedures.23 
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General procedures for the synthesis of ethyl 4H-furo[3,2-b]indole-4-carboxylates 1a-j. 
According to the reaction sequence reported in Scheme 3, 4H-furo[3,2-b]indole-4-carboxylates 1a-f 
were synthesized in a four steps procedure according to the ensuing general procedures. 
Step 1. To a N2-flushed solution of furan-2-ylboronic acid (1.5 equiv.), potassium carbonate (4.0 
equiv.), PdCl2(PPh3)2 (5 mol%) in DMF and water (4.4:1), 2-bromoaniline (1.0 equiv.) was added. 
The reaction mixture was heated at reflux for 3 h and then cooled at room temperature. The mixture 
was diluted with water and extracted with ethyl acetate. The organic layer was washed with brine, 
dried over Na2SO4, filtered and the solvent concentrated under vacuum. The crude was purified by 
flash column chromatography to yield the corresponding 2-(furan-2-yl)aniline. 
Step 2 (method A). To a solution of 2-(furan-2-yl)aniline (1.0 equiv.), an aqueous solution of 
hydrochloric acid (15%.) was added dropwise at 0° C. Then a solution of sodium nitrite (1.2 equiv.) 
in water was added dropwise. The mixture was stirred for 1 h at 0° C. Then a solution of sodium azide 
(2.4 equiv.) in water was added dropwise at 0° C and the mixture was stirred for 1 h at room 
temperature. The mixture was diluted with water, extracted with ethyl acetate, washed with sodium 
bicarbonate saturated solution and brine. The organic layer was dried over Na2SO4 and concentrated. 
The crude was purified by flash column chromatography to yield the corresponding 2-(2-
azidophenyl)furan. 
Step 2 (method B). To a solution of 2-(furan-2-yl)aniline (1.0 equiv.) in CH3CN (0.5 M) at 0° C t-
BuONO (1.2 equiv.) was added, followed by TMSN3 (1.2 equiv.) dropwise. The resulting solution 
was stirred at room temperature for 1 h and then was concentrated in vacuum. Purification by flash 
column chromatography yielded the corresponding 2-(2-azidophenyl)furan. 
Step 3. To a solution of 1,2-dichlorobenzene (final concentration 0.5 M) heated at 160° C, 2-(2-
azidophenyl)furan (1.0 equiv.) was added dropwise. The reaction mixture was stirred for 3 h. Then 
solvent was concentrated under vacuum. The crude was purified by flash column chromatography to 
yield the corresponding 4H-furo[3,2-b]indole. 
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Step 4. To a N2-flushed solution of appropriate 4H-furo[3,2-b]indole (1.0 equiv.) in THF (0.1 M), a 
solution of n-butyllithium (1.6 M in hexane, 1.1 equiv.) was added dropwise at -78° C. The reaction 
mixture was stirred for 30 minutes. Ethyl chloroformate (1.5 equiv.) was added dropwise and the 
reaction was brought to room temperature and stirred for 2 h before of being quenched with 
ammonium chloride saturated solution. The organic layer was extracted with ethyl acetate, dried over 
Na2SO4, filtered and the solvent concentrated under vacuum. The crude was purified by flash column 
chromatography to yield the corresponding ethyl 4H-furo[3,2-b]indole-4-carboxylate. 
2-(furan-2-yl)aniline General procedure was followed using furan-2-ylboronic acid (487 mg, 4.35 
mmol), potassium carbonate (1.60 g, 11.6 mmol), PdCl2(PPh3)2 (102 mg, 0.145 
mmol), 2-bromoaniline (500 mg, 2.9 mmol) in DMF (13 mL) and water (3 mL). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 2-(furan-2-
yl)aniline (344 mg, 98%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.54 - 7.43 (m, 2H), 7.11 (m, 
1H), 6.83 - 6.69 (m, 2H), 6.58 (d, J = 3.4 Hz, 1H), 6.51 (dd, J = 3.3, 1.9 Hz, 1H), 4.35 (s, 2H). Data 
are in agreement with those reported in literature.17 
2-(2-azidophenyl)furan General procedure (method A) was followed using 2-(furan-2-yl)aniline 
(1.55 g, 9.76 mmol), a solution of HCl (1.96 mL, 64.42 mmol) in water (9 mL), a 
solution of sodium nitrite (1.62 g, 23.42 mmol) in water (7.6 mL), a solution of sodium 
azide (1.52 g, 23.42 mmol) in water (12.4 mL). Purification by flash column chromatography (SiO2, 
hexane 100%), yielded 2-(2-azidophenyl)furan (1.68 g, 93%) as brownish oil. 1H NMR (300 MHz, 
CDCl3): 7.85 (d, J = 7.7 Hz, 1H), 7.48 (s, 1H), 7.45 - 7.12 (m, 3H), 7.08 (d, J = 3.2 Hz, 1H), 6.51 (s, 
1H). Data are in agreement with those reported in literature.17 
4H-furo[3,2-b]indole General procedure was followed using 1,2-dichlorobenzene (14.5 mL), 2-(2-
azidophenyl)furan (1.63 g, 8.81 mmol). Purification by flash column chromatography 
(SiO2, hexane 100%), yielded 4H-furo[3,2-b]indole (1.02 g, 73%) as reddish oil. 
1H 
NMR (300 MHz, CDCl3): 7.71 (m, 1H), 7.55 (d, J = 2.0 Hz, 1H), 7.40 (m, 1H), 7.26 - 7.07 (m, 2H), 
6.59 (d, J = 2.0 Hz, 1H), 5.30 (s, 1H). Data are in agreement with those reported in literature.17 
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Ethyl 4H-furo[3,2-b]indole-4-carboxylate (1a). General procedure was followed using 4H-furo[3,2-
b]indole (250 mg, 1.6 mmol), n-butyllithium (1.6 M in hexane, 1.1 mL, 1.76 mmol), ethyl 
chloroformate (230 μL, 2.4 mmol) in THF (16 mL). Purification by flash column chromatography 
(SiO2, hexane/ethyl acetate 95:5), yielded 1a (277 mg, 75%) as orange solid (m.p. 60-61.9° C). 
1H 
NMR (300 MHz, CDCl3): 8.34 (bs, 1H), 7.67 (m, 1H), 7.54 (d, J = 2.0 Hz, 1H), 7.35 - 7.25 (m, 2H), 
6.82 (bs, 1H), 4.52 (q, J = 7.1 Hz, 2H), 1.51 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 
151.1 (C), 145.8 (CH), 143.5 (C), 138.8 (C), 129.5 (C), 124.0 (CH), 123.4 (CH), 118.1 (C), 116.4 
(CH), 116.4 (CH), 103.1 (CH), 63.0 (CH2), 14.5 (CH3). EI-MS: m/z(%) = 229 (100) [M]
+. Anal. 
Calcd for C13H11NO3: C, 68.11; H, 4.84; N, 6.11. Found: C, 67.99; H, 4.83; N, 6.12. 
2-(5-methylfuran-2-yl)aniline General procedure was followed using (5-methylfuran-2-yl)boronic 
acid (548 mg, 4.35mmol), potassium carbonate (1.60 g, 11.6 mmol), PdCl2(PPh3)2 
(102 mg, 0.145 mmol), 2-bromoaniline (500 mg, 2.9 mmol) in DMF (13 mL) and 
water (3 mL). Purification by flash column chromatography (SiO2, hexane/ethyl 
acetate 9:1), yielded 2-(5-methylfuran-2-yl)aniline (480 mg, 95%) as brownish oil. 1H NMR (300 
MHz, CDCl3): 7.46 (dd, J = 7.7, 1.3 Hz, 1H), 7.09 (ddd, J = 8.0, 7.3, 1.6 Hz, 1H), 6.85 - 6.68 (m, 
2H), 6.47 (d, J = 3.2 Hz, 1H), 6.10 (m, 1H), 4.44 (d, J = 0.7 Hz, 2H), 2.38 (s, 3H). 13C{1H} NMR (75 
MHz, CDCl3): 151.6 (C), 151.1 (C), 143.0 (C), 128.2 (CH), 127.2 (CH), 118.4 (CH), 116.60 (C), 
116.58 (CH), 107.4 (CH), 107.3 (CH), 13.7 (CH3). ESI(+)-MS: m/z(%) = 174 (100) [M+H]
+. Anal. 
Calcd for C11H11NO: C, 76.28; H, 6.40; N, 8.09. Found: C, 76.35; H, 6.39; N, 8.10. 
2-(2-azidophenyl)-5-methylfuran General procedure (method A)  was followed using 2-(furan-2-yl)-
4-methylaniline (2.14 g, 12.4 mmol), HCl (15%, 12.4 mL), a solution of sodium 
nitrite (1.03 g, 14.88 mmol) in water (31 mL), a solution of sodium azide (1.31 g, 
20.2 mmol) in water (4.7 mL). Purification by flash column chromatography (SiO2, 
hexane 100%), yielded 2-(2-azidophenyl)-5-methylfuran (1.71 g, 69%) as yellow oil. 1H NMR (300 
MHz, CDCl3): 7.84 (dd, J = 7.7, 1.2 Hz, 1H), 7.30 - 7.11 (m, 3H), 6.98 (d, J = 3.2 Hz, 1H), 6.09 (m, 
1H), 2.39 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 152.2 (C), 148.3 (C), 134.9 (C), 127.8 (CH), 
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126.7 (CH), 125.3 (CH), 123.1 (C), 119.2 (CH), 111.9 (CH), 108.3 (CH), 14.1 (CH3). Anal. Calcd 
for C11H9N3O: C, 66.32; H, 4.55; N, 21.09. Found: C, 66.36; H, 4.54; N, 21.11. 
2-methyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene (3.2 
mL), 2-(2-azidophenyl)-5-methylfuran (400 mg, 2 mmol). Purification by flash 
column chromatography (SiO2, hexane 100% to hexane/ethyl acetate 95:5), 
yielded 2-methyl-4H-furo[3,2-b]indole (269 mg, 79%) as reddish oil. 1H NMR (300 MHz, CDCl3): 
7.68 (m, 1H), 7.55 (bs, 1H), 7.37 (m, 1H), 7.18 - 7.08 (m, 2H), 6.21 (d, J = 1.0 Hz, 1H), 2.50 (d, J = 
1.0 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 156.1 (C), 140.7 (C), 139.0 (C), 131.0 (C), 120.8 
(CH), 119.7 (CH), 115.5 (CH), 114.8 (C), 112.0 (CH), 95.8 (CH), 14.9 (CH3). ESI(+)-MS: m/z(%) = 
172 (100) [M+H]+. Anal. Calcd for C11H9NO: C, 77.17; H, 5.30; N, 8.18. Found: C, 77.26; H, 5.29; 
N, 8.17. 
Ethyl 2-methyl-4H-furo[3,2-b]indole-4-carboxylate (1b). General procedure was followed using 2-
methyl-4H-furo[3,2-b]indole (107 mg, 0.63 mmol), n-butyllithium (1.6 M in hexane, 430 µL, 0.69 
mmol), ethyl chloroformate (90 μL, 0.95 mmol) in THF (6.2 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 1b (122 mg, 79%) as orange solid (m.p. 
107.1-108.2° C). 1H NMR (300 MHz, CDCl3): 8.30 (s, 1H), 7.59 (m, 1H), 7.32 - 7.19 (m, 2H), 6.44 
(s, 1H), 4.50 (q, J = 7.1 Hz, 2H), 2.49 (d, J = 0.8 Hz, 3H), 1.49 (t, J = 7.1 Hz, 3H). 13C{1H} NMR 
(75 MHz, CDCl3): 156.2 (C), 151.2 (C), 141.7 (C), 137.9 (C), 130.3 (C), 123.2 (CH), 123.1 (CH), 
118.3 (C), 116.2 (CH), 115.6 (CH), 99.4 (CH), 62.9 (CH2), 14.7 (CH3), 14.4 (CH3). ESI(+)-MS: 
m/z(%) = 244 (100) [M+H]+. Anal. Calcd for C14H13NO3: C, 69.12; H, 5.39; N, 5.76. Found: C, 68.97; 
H, 5.40; N, 5.75. 
4-methyl-2-(5-methylfuran-2-yl)aniline. General procedure was followed using (5-methylfuran-2-
yl)boronic acid (1.89 g, 15 mmol), potassium carbonate (5.50 g, 40 mmol), 
PdCl2(PPh3)2 (350 mg, 0.5 mmol), 2-bromo-4-methylaniline (1.86 g, 10 mmol) 
in DMF (45 mL) and water (10 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 4-methyl-2-(5-methylfuran-2-yl)aniline 
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(1.26 g, 65%) as orange oil. 1H NMR (300 MHz, CDCl3): 7.32 (m, 1H), 6.93 (dd, J = 7.9, 1.7 Hz, 
1H), 6.68 (d, J = 8.1 Hz, 1H), 6.48 (d, J = 3.2 Hz, 1H), 6.13 (m, 1H), 4.08 (bs, 2H), 2.40 (s, 3H), 2.30 
(s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 151.6 (C), 151.0 (C), 140.4 (C), 129.0 (CH), 127.7 (C), 
127.4 (CH), 116.8 (CH), 116.6 (C), 107.4 (CH), 107.3 (CH), 20.5 (CH3), 13.7 (CH3). ESI(+)-MS: 
m/z(%) = 188 (100) [M+H]+. Anal. Calcd for C12H13NO: C, 76.98; H, 7.00; N, 7.48. Found: C, 76.83; 
H, 6.99; N, 7,47. 
2-(2-azido-5-methylphenyl)-5-methylfuran. General procedure (method A) was followed using 4-
methyl-2-(5-methylfuran-2-yl)aniline (1.22 g, 6.5 mmol), HCl (15%, 6.5 mL), 
a solution of sodium nitrite (538 mg, 7.8 mmol) in water (16 mL), a solution of 
sodium azide (689 mg, 10.6 mmol) in water (2.4 mL). Purification by flash 
column chromatography (SiO2, hexane 100%), yielded 2-(2-azido-5-methylphenyl)-5-methylfuran 
(1.06 g, 77%) as orange oil. 1H NMR (300 MHz, CDCl3): 7.63 (m, 1H), 7.14 - 7.03 (m, 2H), 6.94 (d, 
J = 3.3 Hz, 1H), 6.09 (m, 1H), 2.38 (m, 3H), 2.37 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 151.6 
(C), 148.1 (C), 134.5 (C), 131.9 (C), 128.2 (CH), 126.8 (CH), 122.5 (C), 118.7 (CH), 111.4 (CH), 
107.9 (CH), 20.9 (CH3), 13.6 (CH3). Anal. Calcd for C12H11N3O: C, 67.59; H, 5.20; N, 19.71. Found: 
C, 67.45; H, 5.19; N, 19.74. 
2,7-dimethyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene (8.5 
mL), 2-(2-azido-5-methylphenyl)-5-methylfuran (1.02 g, 4.81 mmol). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 
95:5), yielded 2,7-dimethyl-4H-furo[3,2-b]indole (0.56 g, 63%) as reddish waxy solid. 1H NMR (300 
MHz, CDCl3): 7.54 - 7.29 (m, 2H), 7.27 (d, J = 8.5 Hz, 1H), 6.99 (dd, J = 8.3, 1.2 Hz, 1H), 6.21 (d, 
J = 0.9 Hz, 1H), 2.52 (d, J = 0.9 Hz, 3H), 2.50 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 155.9 (C), 
140.5 (C), 137.4 (C), 131.3 (C), 129.1 (C), 122.2 (CH), 115.4 (CH), 114.9 (C), 111.7 (CH), 95.9 
(CH), 21.5 (CH3), 15.0 (CH3). ESI(-)-MS: m/z(%) = 184 (100) [M-H]
-. Anal. Calcd for C12H11NO: 
C, 77.81; H, 5.99; N, 7.56. Found: C, 77.96; H, 6.00; N, 7.57. 
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Ethyl 2,7-dimethyl-4H-furo[3,2-b]indole-4-carboxylate (1c). General procedure was followed using 
2,7-dimethyl-4H-furo[3,2-b]indole (500 mg, 2.7 mmol), n-butyllithium (1.6 M in hexane, 1.85 mL, 
2.97 mmol), ethyl chloroformate (388 μL, 4.05 mmol) in THF (28 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 98:2), yielded 1c (431 mg, 62%) as pink solid (m.p. 93.8-
94.5° C). 1H NMR (300 MHz, CDCl3): 8.14 (s, 1H), 7.37 (s, 1H), 7.06 (d, J = 8.4 Hz, 1H), 6.43 (s, 
1H), 4.49 (q, J = 7.1 Hz, 2H), 2.48 (s, 3H), 2.45 (s, 3H), 1.49 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 
MHz, CDCl3): 156.0 (C), 151.1 (C), 141.6 (C), 136.1 (C), 132.8 (2xC), 124.2 (CH), 118.4 (C), 115.84 
(CH), 115.78 (CH), 99.4 (CH), 62.7 (CH2), 21.4 (CH3), 14.7 (CH3), 14.4 (CH3). ESI(+)-MS: m/z(%) 
= 258 (100) [M+H]+. Anal. Calcd for C15H15NO3: C, 70.02; H, 5.88; N, 5.44. Found: C, 69.93; H, 
5.87; N, 5.45. 
4-fluoro-2-(5-methylfuran-2-yl)aniline. General procedure was followed using (5-methylfuran-2-
yl)boronic acid (1.49 g, 11.8 mmol), potassium carbonate (4.40 g, 31.6 mmol), 
PdCl2(PPh3)2 (273 mg, 0.39 mmol), 2-bromo-4-fluoroaniline (900 µL, 7.9 mmol) 
in DMF (35 mL) and water (8 mL). Purification by flash column chromatography 
(SiO2, hexane/ethyl acetate 95:5), yielded (1.31 g, 87%) as orange oil. 
1H NMR (300 MHz, CDCl3): 
7.19 (dd, J = 9.9, 2.9 Hz, 1H), 6.79 (td, J = 8.4, 2.9 Hz, 1H), 6.66 (dd, J = 8.8, 4.9 Hz, 1H), 6.50 (d, 
J = 3.2 Hz, 1H), 6.10 (m, 1H), 4.14 (s, 2H), 2.38 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 156.2 (d, 
J = 235 Hz, C), 151.6 (C), 150.3 (d, J = 2.8 Hz, C), 138.8 (d, J = 2.0 Hz, C), 117.6 (d, J = 8.0 Hz, 
CH), 117.5 (C), 114.7 (d, J = 22.7 Hz, CH), 112.9 (d, J = 24.0 Hz, CH), 108.3 (CH), 107.5 (CH), 
13.6 (CH3). ESI(+)-MS: m/z (%) = 192 (100) [M+H]
+. Anal. Calcd for C12H10FNO: C, 69.10; H, 
5.27; N, 7.33. Found: C, 68.91; H, 5.25; N, 7.54. 
2-(2-azido-5-fluorophenyl)-5-methylfuran. General procedure (method A) was followed using 4-
fluoro-2-(5-methylfuran-2-yl)aniline (1.30 g, 6.7 mmol), HCl (15%, 6.7 mL), a 
solution of sodium nitrite (554 mg, 8.04 mmol) in water (18 mL), a solution of 
sodium azide (709 mg, 10.9 mmol) in water (2.5 mL). Purification by flash 
column chromatography (SiO2, hexane 100%), yielded 2-(2-azido-5-fluorophenyl)-5-methylfuran 
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(881 mg, 61%) as yellow oil. 1H NMR (300 MHz, CDCl3): 7.52 (dd, J = 10, 2.9 Hz, 1H), 7.13 (dd, J 
= 8.8, 4.7 Hz, 1H), 7.02 (d, J = 3.3 Hz, 1H), 6.94 (ddd, J = 8.8, 7.5, 3.0 Hz, 1H), 6.11 (m, 1H), 2.41 
- 2.33 (m, 3H). 13C{1H} NMR (75 MHz, CDCl3): 160.0 (d, J = 243 Hz, C), 152.3 (C), 146.9 (C), 
130.2 (C), 124.3 (C), 120.1 (d, J = 8.8 Hz, CH), 114.0 (d, J = 23.9 Hz, CH), 112.7 (d, J = 26.4 Hz, 
CH), 112.4 (CH), 108.2 (CH), 13.6 (CH3). Anal. Calcd for C11H8FN3O: C, 60.83; H, 3.71; N, 19.35. 
Found: C, 60.96; H, 3.72; N, 19.31. 
7-fluoro-2-methyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene 
(5.5 mL), 2-(2-azido-5-fluorophenyl)-5-methylfuran (668 mg, 3.08 mmol). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 
9:1), yielded 7-fluoro-2-methyl-4H-furo[3,2-b]indole (548 mg, 94%) as 
reddish oil. 1H NMR (300 MHz, CDCl3): 7.53 (s, 1H), 7.34 - 7.22 (m, 2H), 6.86 (td, J = 9.1, 2.5 Hz, 
1H), 6.20 (d, J = 0.9 Hz, 1H), 2.49 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 157.8 (d, J = 234 Hz, 
C), 156.9 (C), 140.6 (C), 135.5 (C), 133.0 (C), 114.6 (d, J = 10.8 Hz, C), 112.4 (d, J = 9.8 Hz, CH), 
108.5 (d, J = 26.1 Hz, CH), 101.1 (d, J = 25.6 Hz, CH), 95.8 (CH), 14.9 (CH3). ESI(+)-MS: m/z(%) 
= 190 (100) [M+H]+. Anal. Calcd for C11H8FNO: C, 69.83; H, 4.26; N, 7.40. Found: C, 69.73; H, 
4.25; N, 7.41. 
Ethyl 7-fluoro-2-methyl-4H-furo[3,2-b]indole-4-carboxylate (1d). General procedure was followed 
using 7-fluoro-4H-furo[3,2-b]indole (522 mg, 2.9 mmol), n-butyllithium (1.6 M in hexane, 2 mL, 3.2 
mmol), ethyl chloroformate (416 μL, 4.35 mmol) in THF (30 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 98:2), yielded 1d (569 mg, 75%) as orange solid (m.p. 
91-92° C). 1H NMR (300 MHz, CDCl3): 8.23 (s, 1H), 7.23 (dd, J = 8.7, 2.6 Hz, 1H), 6.96 (dt, J = 9.1, 
4.6 Hz, 1H), 6.44 (s, 1H), 4.51 (q, J = 7.1 Hz, 2H), 2.50 (d, J = 1.0 Hz, 3H), 1.51 (t, J = 7.1 Hz, 3H). 
13C{1H} NMR (75 MHz, CDCl3): 159.6 (d, J = 239 Hz, C), 157.0 (C), 150.9 (C), 141.0 (d, J = 3.4 
Hz, C), 134.2 (C), 131.9 (d, J = 4.2 Hz, C), 118.8 (d, J = 10.8 Hz, C), 117.1 (d, J = 9.4 Hz, CH), 110.2 
(d, J = 24.9 Hz, CH), 101.9 (d, J = 26.0 Hz, CH), 99.4 (CH), 63.0 (CH2), 14.8 (CH3), 14.4 (CH3). 
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ESI(+)-MS: m/z(%) = 262 (100) [M+H]+. Anal. Calcd for C14H12FNO3: C, 64.36; H, 4.63; N, 5.36. 
Found: C, 64.25; H, 4.64; N, 5.35 
4-methoxy-2-(5-methylfuran-2-yl)aniline. General procedure was followed using (5-methylfuran-2-
yl)boronic acid (1.39 g, 11.1 mmol), potassium carbonate (4.09 g, 29.6 
mmol), PdCl2(PPh3)2 (260 mg, 0.37 mmol ), 2-bromo-5-methoxyaniline (1.5 
g, 7.4 mmol) in DMF (33 mL) and water (7.5 mL). Purification by flash 
column chromatography (SiO2, hexane/ethyl acetate 9:1), yielded 4-methoxy-2-(5-methylfuran-2-
yl)aniline (1.19 g, 79%) as a red oil. 1H NMR (300 MHz, CDCl3): 7.05 (t, J = 1.7 Hz, 1H), 6.71 (d, J 
= 1.6 Hz, 2H), 6.50 (m, 1H), 6.09 (dt, J = 3.2, 1.0 Hz, 1H), 3.99 (bs, 2H), 3.79 (s, 3H), 2.38 (m, 3H). 
13C{1H} NMR (75 MHz, CDCl3): 152.7 (C), 151.3 (C), 151.1 (C), 136.4 (C), 118.2 (CH), 117.7 (C), 
114.9 (CH), 111.7 (CH), 107.9 (CH), 107.4 (CH), 55.8 (CH3), 13.7 (CH3). ESI(+)-MS: m/z(%) = 204 
(100) [M+H]+. Anal. Calcd for C12H13NO2: C, 70.92; H, 6.45; N, 6.89. Found: C, 71.08; H, 6.47; N, 
6.87. 
2-(2-azido-5-methoxyphenyl)-5-methylfuran. General procedure (method A) was followed using 4-
methoxy-2-  (5-methylfuran-2-yl)aniline (850 mg, 4.2 mmol), HCl (15%, 4.2 
ml), a solution of sodium nitrite (346 mg, 5.04 mmol) in water (10.5 mL), a 
solution of sodium azide (444 mg, 6.8 mmol) in water (1.7 mL). Purification 
by flash column chromatography (SiO2, hexane/ethyl acetate 99:1), yielded 2-(2-azido-5-
methoxyphenyl)-5-methylfuran (242 mg, 25%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.35 
(d, J = 2.9 Hz, 1H), 7.11 (d, J = 8.8 Hz, 1H), 6.98 (d, J = 3.2 Hz, 1H), 6.81 (dd, J = 8.8, 2.9 Hz, 1H), 
6.09 (dd, J = 3.3, 1.0 Hz, 1H), 3.85 (s, 3H), 2.37 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 156.9 (C), 
151.8 (C), 147.8 (C), 127.2 (C), 123.6 (C), 120.0 (CH), 113.7 (CH), 111.8 (CH), 110.9 (CH), 108.0 
(CH), 55.6 (CH3), 13.6 (CH3). Anal. Calcd for C12H11N3O2: C, 62.87; H, 4.84; N, 18.33. Found: C, 
62.79; H, 4.82; N, 18.38. 
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7-methoxy-2-methyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2- 
dichlorobenzene (3 mL), 2-(2-azido-5-methoxyphenyl)-5-methylfuran 
(220 mg, 0.96 mmol). Purification by flash column chromatography (SiO2, 
hexane/ethyl acetate 95:5), yielded 7-methoxy-2-methyl-4H-furo[3,2-
b]indole (76 mg, 39%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.45 (bs, 1H), 7.24 (d, J = 8.9 
Hz, 1H), 7.14 (d, J = 2.5 Hz, 1H), 6.78 (dd, J = 8.9, 2.5 Hz, 1H), 6.18 (d, J = 1.0 Hz, 1H), 3.87 (s, 
3H), 2.49 (d, J = 1.0 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 156.2 (C), 154.1 (C), 140.8 (C), 
134.2 (C), 132.1 (C), 114.8 (C), 112.7 (CH), 110.2 (CH), 98.3 (CH), 95.9 (CH), 55.9 (CH3), 14.9 
(CH3). ESI(+)-MS: m/z(%) = 202 (100) [M+H]
+. Anal. Calcd for C12H11NO2: C, 71.63; H, 5.51; N, 
6.96. Found: C, 71.88; H, 5.49; N, 6.98.  
Ethyl 7-methoxy-2-methyl-4H-furo[3,2-b]indole-4-carboxylate (1e). General procedure was 
followed using 7-methoxy-2-methyl-4H-furo[3,2-b]indole (76 mg, 0.38 mmol), n-butyllithium (1.6 
M in hexane, 260 µL, 0.42 mmol), ethyl chloroformate (56 μL, 0.58 mmol) in THF (11 mL). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 99:1), yielded 1e (80 mg, 
77%) as white solid (m.p. 86.1-88.0° C). 1H NMR (300 MHz, CDCl3): 8.19 (bs, 1H), 7.09 (d, J = 2.5 
Hz, 1H), 6.86 (dd, J = 9.1, 2.6 Hz, 1H), 6.44 (bs, 1H), 4.50 (q, J = 7.1 Hz, 2H), 3.89 (s, 3H), 2.50 (d, 
J = 1.0 Hz, 3H), 1.50 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 156.3 (C), 151.1 (C), 
141.6 (C), 132.5 (C), 130.9 (C), 118.9 (C), 117.0 (CH), 110.8 (CH), 99.5 (CH), 99.4 (CH), 62.8 
(CH2), 55.7 (CH3), 14.8 (CH3), 14.5 (CH3). One quaternary carbon is missing, probably overlapped. 
ESI(+)-MS: m/z(%) = 274 (100) [M+H]+. Anal. Calcd for C15H15NO4: C, 65.92; H, 5.53; N, 5.13. 
Found: C, 66.17; H, 5.54; N, 5.11.  
2-(furan-2-yl)-4-methylaniline. General procedure was followed using furan-2-ylboronic acid (1.95 
g, 17.4 mmol), potassium carbonate (6.41 g, 46.4 mmol), PdCl2(PPh3)2 (407 mg, 
0.58 mmol), 2-bromo-4-methylaniline (2.16 g, 11.6 mmol) in DMF (52 mL) and 
water (12 mL). Purification by flash column chromatography (SiO2, hexane/ethyl acetate 97:3), 
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yielded 2-(furan-2-yl)-4-methylaniline (1.87 g, 93%) as brownish oil. 1H NMR (300 MHz, CDCl3): 
7.52 (m, 1H), 7.32 (d, J = 1.4 Hz, 1H), 6.96 (m, 1H), 6.70 (d, J = 8.1 Hz, 1H), 6.60 (d, J = 3.4 Hz, 
1H), 6.53 (dd, J = 3.4, 1.8 Hz, 1H), 4.13 (bs, 2H), 2.30 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 
153.6 (C), 141.2 (CH), 140.7 (C), 129.6 (CH), 127.9 (CH), 127.7 (C), 117.0 (CH), 116.3 (C), 111.3 
(CH), 106.4 (CH), 20.4 (CH3). ESI(+)-MS: m/z(%) = 174 (100) [M+H]
+. Anal. Calcd for C11H11NO: 
C, 76.28; H, 6.40; N, 8.09. Found: C, 76.43; H, 6.39; N, 8.10. 
2-(2-azido-5-methylphenyl)furan. General procedure (method A) was followed using 2-(furan-2-yl)-
4-methylaniline (1.84 g, 10.62 mmol), a solution of HCl (2.13 mL, 70.09 mmol) 
in water (9.7 mL), a solution of sodium nitrite (1.76 g, 25.49 mmol) in water (9.9 
mL), a solution of sodium azide (1.66 g, 25.49 mmol) in water (13.5 mL). Purification by flash 
column chromatography (SiO2, hexane 100%), yielded 2-(2-azido-5-methylphenyl)furan (1.71 g, 
80%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.66 (s, 1H), 7.47 (d, J = 1.0 Hz, 1H), 7.11 (s, 
2H), 7.05 (d, J = 3.3 Hz, 1H), 6.50 (dd, J = 3.3, 1.8 Hz, 1H). 2.37 (s, 3H). 13C{1H} NMR (75 MHz, 
CDCl3): 149.8 (C), 141.6 (CH), 134.6 (C), 132.4 (C), 128.8 (CH), 127.3 (CH), 122.2 (C), 118.8 (CH), 
111.7 (CH), 110.2 (CH), 20.9 (CH3). Anal. Calcd for C11H9N3O: C, 66.32; H, 4.55; N, 21.09. Found: 
C, 66.47; H, 4.55; N, 21.08. 
7-methyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene (8 mL), 
2-(2-azido-5-methylphenyl)furan (1.02 g, 5.09 mmol). Purification by flash 
column chromatography (SiO2, hexane 100% to hexane/ethyl acetate 95:5), 
yielded 7-methyl-4H-furo[3,2-b]indole (834 mg, 95%) as reddish oil in a mixture with unidentified 
inseparable impurity. 1H NMR (300 MHz, CDCl3) for 7-methyl-4H-furo[3,2-b]indole: 7.53 (m, 3H), 
7.27 (m, 1H), 7.03 (m, 1H), 6.55 (d, J = 2.1 Hz, 1H), 2.48 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 
145.6 (CH), 138.4 (C), 130.3 (C), 129.2 (C), 126.7 (C), 123.1 (CH), 116.1 (CH), 114.8 (C), 111.8 
(CH), 99.4 (CH), 21.4 (CH3). ESI(+)-MS: m/z(%) = 172 (100) [M+H]
+. Anal. Calcd for C11H9NO: 
C, 77.17; H, 5.30; N, 8.18. Found: C, 77.38; H, 5.31; N, 4.17. 
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Ethyl 7-methyl-4H-furo[3,2-b]indole-4-carboxylate (1f). General procedure was followed using 7-
methyl-4H-furo[3,2-b]indole (800 mg, 4.67 mmol), n-butyllithium (1.6 M in hexane, 3.2 mL, 5.14 
mmol), ethyl chloroformate (668 μL, 7 mmol) in THF (46 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 1f (829 mg, 73%) as orange solid (m.p. 
95-95.7° C). 1H NMR (300 MHz, CDCl3): 8.17 (bs, 1H), 7.51 (d, J = 1.9 Hz, 1H), 7.45 (dd, J = 1.6, 
0.8 Hz, 1H), 7.12 (dd, J = 8.5, 1.2 Hz, 1H). 6.79 (s, 1H), 4.51 (q, J = 7.1 Hz, 2H), 2.47 (s, 3H), 1.50 
(t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 151.0 (C), 145.6 (CH), 143.4 (C), 137.0 (C), 
133.0 (C), 129.6 (C), 125.1 (CH), 118.2 (C), 116.4 (CH), 116.0 (CH), 103.0 (CH), 62.9 (CH2), 21.3 
(CH3), 14.4 (CH3). ESI(+)-MS: m/z(%) = 266 (100) [M+Na]
+. Anal. Calcd for C14H13NO3: C, 69.12; 
H, 5.39; N, 5.76. Found: C, 69.26; H, 5.40; N, 5.77. 
4-fluoro-2-(furan-2-yl)aniline. General procedure was followed using furan-2-ylboronic acid (2.65 g, 
23.68 mmol), potassium carbonate (8.73 g, 63.16 mmol), PdCl2(PPh3)2 (8.73 g, 
63.16 mmol), 2-bromo-4-fluoroaniline (3.00 g, 15.79 mmol) in DMF (71 mL) and 
water (16 mL). Purification by flash column chromatography (SiO2, hexane/ethyl acetate 9:1), yielded 
4-fluoro-2-(furan-2-yl)aniline (3.08 g, 100%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.50 (dd, 
J = 1.8, 0.7 Hz, 1H), 7.20 (dd, J = 9.8, 2.9 Hz, 1H), 6.83 (ddd, J = 8.8, 7.9, 2.9 Hz, 1H), 6.68 (dd, J 
= 8.8, 4.8 Hz, 1H), 6.61 (dd, J = 3.4, 0.7 Hz, 1H), 6.52 (dd, J = 3.4, 1.9 Hz, 1H), 4.18 (bs, 2H). 
13C{1H} NMR (75 MHz, CDCl3): 156.1 (d, J = 235 Hz, C), 152.2 (d, J = 2.6 Hz, C), 141.6 (CH), 
139.2 (d, J = 1.7 Hz, C), 117.7 (d, J = 7.8 Hz, CH), 117.0 (d, J = 7.8 Hz, C), 115.4 (d, J = 22.8 Hz, 
CH), 113.3 (d, J = 23.9 Hz, CH), 111.4 (CH), 107.2 (CH). ESI(+)-MS: m/z(%) = 178 (100) [M+H]+. 
Anal. Calcd for C10H8FNO: C, 67.79; H, 4.55; N, 7.91. Found: C, 67.66; H, 4.56; N, 7.92. 
2-(2-azido-5-fluorophenyl)furan. General procedure (method A) was followed using 4-fluoro-2-
(furan-2-yl)aniline (3.02 g, 17.07 mmol), a solution of HCl (3.42 mL, 112.66 
mmol) in water (15 mL), a solution of sodium nitrite (2.83 g, 40.97 mmol) in water 
(15 mL), a solution of sodium azide (2.66 g, 40.97 mmol) in water (22 mL). Purification by flash 
column chromatography (SiO2, hexane 100%), yielded 2-(2-azido-5-fluorophenyl)furan (1.42 g, 
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41%) as brownish oil. 1H NMR (300 MHz, CDCl3): 7.58 (dd, J = 9.8, 2.9 Hz, 1H), 7.50 (d, J = 1.1 
Hz, 1H), 7.19 - 7.12 (m, 2H), 7.01(ddd, J = 8.8, 7.5, 2.9 Hz, 1H), 6.54 (ddd, J = 3.5, 1.8, 0.7 Hz, 1H). 
13C{1H} NMR (75 MHz, CDCl3): 160.3 (d, J = 243 Hz, C), 149.2 (C), 142.8 (CH), 131.3 (d, J = 2.6 
Hz, C), 124.4 (d, J = 8.7 Hz, C), 120.8 (d, J = 8.7 Hz, CH), 115.3 (d, J = 23.7 Hz, CH), 113.8 (d, J = 
25.3 Hz, CH), 112.5 (CH), 111.9 (CH). Anal. Calcd for C10H6FN3O: C, 59.12; H, 2.98; N, 20.68. 
Found: C, 59.23; H, 2.97; N, 20.60. 
7-fluoro-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene (11 mL), 
2-(2-azido-5-fluorophenyl)furan (1.37 g, 6.7 mmol). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 7-fluoro-4H-furo[3,2-
b]indole (788 mg, 67%) as reddish wax. 1H NMR (300 MHz, CDCl3): 7.64 (bs, 1H), 7.58 (d, J = 2.1 
Hz, 1H), 7.41 (dd, J = 9.3, 2.5 Hz, 1H), 7.32 (dd, J = 8.9, 4.3 Hz, 1H), 6.99 (td, J = 9.1, 2.6 Hz, 1H), 
6.58 (d, J = 2.1 Hz, 1H). 13C{1H} NMR (75 MHz, CDCl3): 158.2 (d, J = 235 Hz, C), 146.9 (CH), 
142.5 (C), 136.8 (C), 132.2 (C), 114.9 (C), 113.1 (d, J = 9.7 Hz CH), 110.0 (d, J = 26.1 Hz, CH), 
102.2 (d, J = 25.6 Hz, CH), 99.9 (CH). ESI(-)-MS: m/z(%) = 174 (100) [M-H]-. Anal. Calcd for 
C10H6FNO: C, 68.57; H, 3.45; N, 8.00. Found: C, 68.54; H, 3.46; N, 7.99. 
Ethyl 7-fluoro-4H-furo[3,2-b]indole-4-carboxylate (1g). General procedure was followed using 7-
fluoro-4H-furo[3,2-b]indole (765 mg, 4.37 mmol), n-butyllithium (1.6 M in hexane, 3 mL, 4.81 
mmol), ethyl chloroformate (627 μL, 6.55 mmol) in THF (43 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 99:1), yielded 1g (855 mg, 79%) as orange solid (m.p. 
60-61° C). 1H NMR (300 MHz, CDCl3): 8.27 (bs, 1H), 7.56 (d, J = 2.0 Hz, 1H), 7.33 (dd, J = 8.6, 2.6 
Hz, 1H), 7.03 (td, J = 9.1, 2.6 Hz, 1H), 6.82 (s, 1H), 4.53 (q, J = 7.1 Hz, 2H), 1.52 (t, J = 7.1 Hz, 3H). 
13C{1H} NMR (75 MHz, CDCl3): 159.5 (d, J = 240 Hz, C), 150.9 (C), 146.4 (CH), 142.8 (C), 135.0 
(C), 131.0 (C), 118.6 (d, J = 10.9 Hz, C), 117.3 (d, J = 9.2 Hz, CH), 111.2 (d, J =25.3 Hz, CH), 103.1 
(CH), 102.6 (d, J = 25.9 Hz, CH), 63.2 (CH2), 14.4 (CH3). ESI(+)-MS: m/z(%) = 248 (100) [M+H]
+. 
Anal. Calcd for C13H10FNO3: C, 63.16; H, 4.08; N, 5.67. Found: C, 63.24; H, 4.07; N, 5.68. 
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5-fluoro-2-(5-methylfuran-2-yl)aniline. General procedure was followed using (5-methylfuran-2- 
yl)boronic acid (1.13 g, 9 mmol), potassium carbonate (3.30 g, 24 mmol), 
PdCl2(PPh3)2 (211 mg, 0.3 mmol ), 2-bromo-5-fluoroaniline (1.14 g, 6 mmol) in 
DMF (27 mL) and water (6 mL). Purification by flash column chromatography 
(SiO2, hexane/ethyl acetate 9:1), yielded 5-fluoro-2-(5-methylfuran-2-yl)aniline (907 mg, 79%) as a 
yellow oil. 1H NMR (300 MHz, CDCl3): 7.39 (dd, J = 8.6, 6.4 Hz, 1H), 6.51 (dd, J = 8.4, 2.5 Hz, 
1H), 6.47 (m, 1H), 6.42 (dd, J = 8.4, 2.8 Hz, 1H), 6.10 (m, 1H), 4.39 (bs, 2H), 2.39 (s, 3H). 13C{1H} 
NMR (75 MHz, CDCl3): 163.0 (d, J = 243 Hz, C), 151.1 (C), 150.8 (C), 144.8 (C), 144.7 (d, J = 10.9 
Hz, C), 129.0 (d, J = 10 Hz, CH), 112.9 (d, J = 2.6 Hz, C), 107.2 (d, J = 17.7 Hz, CH), 105.4 (d, J = 
23 Hz, CH), 103.0 (CH), 102.6 (CH), 13.7 (CH3). ESI(+)-MS: m/z(%) = 192 (100) [M+H]
+. Anal. 
Calcd for C11H10FNO: C, 69.10; H, 5.27; N, 7.33. Found: C, 68.84; H, 5.25; N, 7.35. 
2-(2-azido-4-fluorophenyl)-5-methylfuran. General procedure (method B) was followed using 5-
fluoro-2-(5- methylfuran-2-yl)aniline (570 mg, 2.98 mmol), t-BuONO (0.53 ml, 
4.47 mmol) and TMSN3 (0.59 ml, 4.47 mmol) in CH3CN (6 ml). Purification by 
flash column chromatography (SiO2, hexane 100%), yielded 2-(2-azido-4-
fluorophenyl)-5-methylfuran (390 mg, 60%) as a yellow wax. 1H NMR (300 MHz, CDCl3): 7.79 (dd, 
J = 8.6, 6.2 Hz, 1H), 6.96-6.87 (m, 3H), 6.10 (m, 1H), 2.38 (s, 3H). 13C{1H} NMR (75 MHz, CDCl3): 
161.7 (d, J = 249 Hz, C), 151.7 (C), 147.2 (C), 136.1 (d, J = 8 Hz, C), 127.9 (d, J = 11 Hz, CH), 119.2 
(C), 112.2 (d, J = 22 Hz, CH), 110.9 (CH), 107.9 (CH), 106.1 (d, J = 24 Hz, CH), 13.6 (CH3). Anal. 
Calcd for C11H8FN3O: C, 60.83; H, 3.71; N, 19.35. Found: C, 61.04; H, 3.72; N, 19.29. 
6-fluoro-2-methyl-4H-furo[3,2-b]indole. General procedure was followed using 1,2-dichlorobenzene  
(4 mL), 2-(2-azido-4-fluorophenyl)-5-methylfuran (370 mg, 1.71 mmol). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 9:1), 
yielded 6-fluoro-2-methyl-4H-furo[3,2-b]indole (221 mg, 68%) as brownish 
oil. 1H NMR (300 MHz, CDCl3): 7.67-7.48 (m, 2H), 7.08 (dd, J = 9.9, 2.1 Hz, 1H), 6.93 (m, 1H), 
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6.22 (d, J = 1.0 Hz, 1H), 2.50 (d, J = 0.8 Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 159.3 (d, J = 237 
Hz, C), 156.2 (C), 140.7 (C), 139.3 (d, J = 11.8 Hz, C), 131.5 (C), 116.3 (d, J = 10 Hz, CH), 112.1 
(C), 108.4 (d, J = 24.4 Hz, CH), 99.2 (d, J = 26.6 Hz, CH), 96.4 (CH), 15.3 (CH3). ESI(+)-MS: m/z(%) 
= 190 (100) [M+H]+. Anal. Calcd for C11H8FNO: C, 69.84; H, 4.26; N, 7.40. Found: C, 7.02; H, 4.28; 
N, 7.37.  
Ethyl 6-fluoro-2-methyl-4H-furo[3,2-b]indole-4-carboxylate (1h). General procedure was followed 
using 6-fluoro-2-methyl-4H-furo[3,2-b]indole (208 mg, 1.1 mmol), n-butyllithium (1.6 M in hexane, 
760 µL, 1.21 mmol), ethyl chloroformate (158 μL, 1.65 mmol) in THF (11 mL). Purification by flash 
column chromatography (SiO2, hexane/ethyl acetate 99:1 to 98:2), yielded 1h (266 mg, 93%) as white 
solid (m.p. 100.9-102.8° C). 1H NMR (300 MHz, CDCl3): 8.04 (bs, 1H), 7.47 (dd, J = 8.6, 5.4 Hz, 
1H), 7.01 (m, 1H), 6.41 (bs, 1H), 4.49 (q, J = 7.1 Hz, 2H), 2.47 (d, J = 0.9 Hz, 3H), 1.49 (t, J = 7.1 
Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 159.8 (d, J = 240 Hz, C), 156.0 (C), 150.9 (C), 141.1 (C), 
130.4 (C), 115.9 (d, J = 9.6 Hz, CH), 114.9 (C), 111.0 (d, J = 24.2 Hz, CH), 104.1 (d, J = 29.2 Hz, 
CH), 99.4 (CH), 63.1 (CH2), 14.7 (CH3), 14.4 (CH3). One quaternary carbon is missing, probably 
overlapped. ESI(+)-MS: m/z(%) = 262 (100) [M+H]+. Anal. Calcd for C14H12FNO3: C, 64.36; H, 
4.63; N, 5.36. Found: C, 64.44; H, 4.61; N, 5.35. 
5-methoxy-2-(5-methylfuran-2-yl)aniline. General procedure was followed using (5-methylfuran-2- 
yl)boronic acid (1.13 g, 9 mmol), potassium carbonate (3.30 g, 24 mmol), 
PdCl2(PPh3)2 (211 mg, 0.3 mmol ), 2-bromo-5-methoxyaniline (1.21 g, 6 
mmol) in DMF (27 mL) and water (6 mL). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 9:1), yielded 5-methoxy-2-(5-methylfuran-2-yl)aniline 
(903 mg, 74%) as a brownish oil. 1H NMR (300 MHz, CDCl3): 7.35 (d, J = 8.6 Hz, 1H), 6.38 (dd, J 
= 8.6, 2.5 Hz, 1H), 6.33 (d, J = 3.1 Hz, 1H), 6.30 (d, J = 2.4 Hz, 1H), 6.05 (m, 1H), 4.31 (bs, 2H), 
3.78 (s, 3H), 2.36 (s, 3H). 13C {1H} NMR (75 MHz, CDCl3): 160.0 (C), 151.55 (C), 150.51 (C), 144.2 
(C), 128.7 (CH), 110.4 (C), 107.1 (CH), 106.1 (CH), 104.8 (CH), 101.6 (CH), 55.2 (CH3), 13.8 (CH3). 
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ESI(+)-MS: m/z(%) = 204 (100) [M+H]+. Anal. Calcd for C12H13NO2: C, 70.92; H, 6.45; N, 6.89. 
Found: C, 71.08; H, 6.47; N, 6.91. 
2-(2-azido-4-methoxyphenyl)-5-methylfuran. General procedure (method B) was followed using 5- 
methoxy-2-(5-methylfuran-2-yl)aniline (900 mg, 4.43 mmol), t-BuONO 
(0.79 ml, 6.65 mmol) and TMSN3 (0.87 ml, 6.65 mmol) in CH3CN (9 ml). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 
98:2), yielded 2-(2-azido-4-methoxyphenyl)-5-methylfuran (810 mg, 80%) as a yellow wax. 1H NMR 
(300 MHz, CDCl3): 7.73 (dd, J = 7.6, 1.6 Hz, 1H), 6.81 (d, J = 3.2 Hz, 1H), 6.78 – 6.73 (m, 2H), 6.08 
(m, 1H), 3.87 (s, 3H), 2.38 (d, J = 0.4 Hz, 3H). 13C {1H} NMR (75 MHz, CDCl3): 159.1 (C), 151.0 
(C), 148.1 (C), 135.8 (C), 127.6 (CH), 116.3 (C), 110.7 (CH), 109.6 (CH), 107.7 (CH), 104.6 (CH), 
55.5 (CH3), 13.6 (CH3). Anal. Calcd for C12H11N3O2: C, 62.87; H, 4.84; N, 18.33. Found: C, 62.79; 
H, 4.86; N, 18.37. 
6-methoxy-2-methyl-4H-furo[3,2-b]indole.  
General procedure was followed using 1,2-dichlorobenzene (8 mL), 2-(2-
azido-4-methoxyphenyl)-5-methylfuran (808 mg, 3.5 mmol). Purification 
by flash column chromatography (SiO2, hexane/ethyl acetate 9:1), yielded 
6-methoxy-2-methyl-4H-furo[3,2-b]indole (430 mg, 61%) as brownish oil. 1H NMR (300 MHz, 
CDCl3): 7.55 (m, 2H), 6.89 (d, J = 2.2 Hz, 1H), 6.83 (dd, J = 8.6, 2.2 Hz, 1H), 6.19 (s, 1H), 3.86 (s, 
3H), 2.50 (s, 3H). 13C {1H} NMR (75 MHz, CDCl3): 155.4 (C), 154.7 (C), 140.6 (C), 140.0 (C), 129.9 
(C), 116.0 (CH), 109.8 (C), 108.6 (CH), 96.7 (CH), 96.0 (CH), 55.8 (CH3), 14.9 (CH3). ESI(+)-MS: 
m/z(%) = 202 (100) [M+H]+. Anal. Calcd for C12H11NO2: C, 71.63; H, 5.51; N, 6.96. Found: C, 71.88; 
H, 5.50; N, 6.94.   
Ethyl 6-methoxy-2-methyl-4H-furo[3,2-b]indole-4-carboxylate (1i). General procedure was followed 
using 6-methoxy-2-methyl-4H-furo[3,2-b]indole (395 mg, 1.91 mmol), n-butyllithium (1.6 M in 
hexane, 1.3 mL, 2.10 mmol), ethyl chloroformate (274 μL, 2.86 mmol) in THF (11 mL). Purification 
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by flash column chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 1i (447 mg, 86%) as white 
solid (m.p. 95.6-97.7 ° C). 1H NMR (300 MHz, CDCl3): 7.93 (bs, 1H), 7.45 (d, J = 8.6 Hz, 1H), 6.89 
(dd, J = 8.6, 2.4 Hz, 1H), 6.40 (bs, 1H), 4.48 (q, J = 7.1 Hz, 2H), 3.88 (s, 3H), 2.46 (d, J = 1.0 Hz, 
3H), 1.49 (t, J = 7.1 Hz, 3H). 13C {1H} NMR (75 MHz, CDCl3): 156.8 (C), 154.9 (C), 151.2 (C), 
141.7 (C), 139.1 (C), 129.0 (C), 116.0 (CH), 112.7 (C), 111.5 (CH), 101.5 (CH), 99.5 (CH), 62.8 
(CH2), 55.7 (CH3), 14.6 (CH3), 14.4 (CH3). ESI(+)-MS: m/z(%) = 274 (100) [M+H]
+. Anal. Calcd 
for C15H15NO4: C, 65.92; H, 5.53; N, 5.13. Found: C, 65.84; H, 5.51; N, 5.14. 
2-(5-methylfuran-2-yl)-5-(trifluoromethyl)aniline. General procedure was followed using (5- 
methylfuran-2-yl)boronic acid (1.13 g, 9 mmol), potassium carbonate (3.30 g, 
24 mmol), PdCl2(PPh3)2 (211 mg, 0.3 mmol ), 2-bromo-5-
(trifluoromethyl)aniline (1.44 g, 6 mmol) in DMF (27 mL) and water (6 mL). 
Purification by flash column chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 2-(5-
methylfuran-2-yl)-5-(trifluoromethyl)aniline (1.37 mg, 95%) as a white wax. 1H NMR (500 MHz, 
CDCl3): 7.56 (d, J = 8.1 Hz, 1H), 7.02 (d, J = 8.2 Hz, 1H), 6.98 (s, 1H), 6.58 (d, J = 3.3 Hz, 1H), 6.15 
(m, 1H), 4.54 (bs, 2H), 2.42 (s, 3H). 13C {1H} NMR (125 MHz, CDCl3): 152.0 (C), 150.4 (C), 142.8 
(C), 129.9 (q, J = 33.8 Hz, C), 127.3 (CH), 122.2 (q, J = 272 Hz, C), 119.2 (C), 114.8 (q, J = 3.4 Hz, 
CH), 113.2 2 (q, J = 3.9 Hz, CH), 108.9 (CH), 107.7 (CH), 13.7 (CH3). ESI(+)-MS: m/z(%) = 242 
(100) [M+H]+. Anal. Calcd for C12H10F3NO: C, 59.75; H, 4.18; N, 5.81. Found: C, 59.91; H, 4.17; N, 
5.83. 
2-(2-azido-4-(trifluoromethyl)phenyl)-5-methylfuran. General procedure (method B) was followed 
using 2-(5-methylfuran-2-yl)-5-(trifluoromethyl)aniline (1.35 mg, 5.6 mmol), 
t-BuONO (1.0 ml, 8.4 mmol) and TMSN3 (1.1 ml, 8.4 mmol) in CH3CN (11 
ml). Purification by flash column chromatography (SiO2, hexane), yielded 2-
(2-azido-4-(trifluoromethyl)phenyl)-5-methylfuran (1.33 g, 99%) as a yellow wax. 1H NMR (300 
MHz, CDCl3): 7.92 (d, J = 8.6 Hz, 1H), 7.42-7.37 (m, 2H), 7.10 (d, J = 3.3 Hz, 1H), 6.14 (m, 1H), 
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2.39 (s, 3H).13C {1H} NMR (75 MHz, CDCl3): 152.9 (C), 146.7 (C), 134.9 (C), 129.0 (q, J = 32.8 
Hz, C), 126.4 (CH), 125.5 (C), 121.9 (q, J = 271 Hz, C), 121.6 (q, J = 3.9 Hz, CH), 115.7 (q, J = 3.8 
Hz, CH), 113.7 (CH), 108.4 (CH), 13.6 (CH3). Anal. Calcd for C12H8F3N3O: C, 53.94; H, 3.02; N, 
15.73. Found: C, 54.11; H, 3.01; N, 15.69. 
2-methyl-6-(trifluoromethyl)-4H-furo[3,2-b]indole. General procedure was followed using 1,2- 
dichlorobenzene (10.5 mL), 2-(2-azido-4-(trifluoromethyl)phenyl)-5-
methylfuran (1.3 g, 4.9 mmol). Purification by flash column 
chromatography (SiO2, hexane/ethyl acetate 90:10), yielded 2-methyl-6-
(trifluoromethyl)-4H-furo[3,2-b]indole (873 mg, 74%) as reddish solid (m.p. 149.3-151.9 °C). 1H-
NMR (500 MHz, CDCl3): 7.81 (s, 1H), 7.74 (d, J = 8.3 Hz, 1H), 7.65 (m, 1H), 7.42 (dd, J = 8.4, 1.0 
Hz, 1H), 6.27 (d, J = 0.9 Hz, 1H), 2.54 (d, J = 0.8 Hz, 3H). 13C {1H} NMR (125 MHz, CDCl3): 158.0 
(C), 140.0 (C), 137.6 (C), 133.6 (C), 125.2 (q, J = 271 Hz, C), 122.5 (q, J = 32 Hz, C), 116.7 (q, J = 
3.9 Hz, CH), 116.3 (C), 115.5 (CH), 109.4 (q, J = 4.2 Hz, CH), 95.9 (CH), 15.0 (CH3). ESI(+)-MS: 
m/z(%) = 240 (100) [M+H]+. Anal. Calcd for C12H8F3NO: C, 60.26; H, 3.37; N, 5.86. Found: C, 
60.17; H, 3.38; N, 5.84. 
Ethyl 2-methyl-6-(trifluoromethyl)-4H-furo[3,2-b]indole-4-carboxylate (1j). General procedure was 
followed using 2-methyl-6-(trifluoromethyl)-4H-furo[3,2-b]indole (500 mg, 2.1 mmol), n-
butyllithium (1.6 M in hexane, 1.4 mL, 2.3 mmol), ethyl chloroformate (301 μL, 3.2 mmol) in THF 
(21 mL). Purification by flash column chromatography (SiO2, hexane/ethyl acetate 95:5), yielded 1j 
(628 mg, 96%) as yellow solid (m.p. 107.5-109.6 ° C). 1H-NMR (300 MHz, CDCl3): 8.57 (s, 1H), 
7.60 (d, J = 8.3 Hz, 1H), 7.50 (dd, J = 8.3, 1.0 Hz, 1H), 6.42 (s, 1H), 4.51 (q, J = 7.1 Hz, 2H), 2.49 
(d, J = 0.7 Hz, 3H), 1.50 (t, J = 7.1 Hz, 3H). 13C {1H} NMR (75 MHz, CDCl3): 158.0 (C), 150.7 (C), 
140.6 (C), 136.8 (C), 132.7 (C), 124.7 (q, J = 271 Hz, C), 124.7 (q, J = 31.4 Hz, C), 120.2 (q, J = 4.1 
Hz, CH), 120.1 (C), 115.5 (CH), 113.6 (q, J = 4.3 Hz, CH), 99.4 (CH), 63.4 (CH2), 14.8 (CH3), 14.3 
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(CH3). ESI(+)-MS: m/z(%) = 312 (100) [M+H]
+. Anal. Calcd for C15H12F3NO3: C, 57.88; H, 3.89; 
N, 4.50. Found: C, 58.02; H, 3.88; N, 4.48.   
Ethyl 2-bromo-4H-furo[3,2-b]indole-4-carboxylate. To a N2 flushed solution of ethyl 4H-furo[3,2- 
b]indole-4-carboxylate (150 mg, 0.65 mmol) in 1,2-dichloroethane (6.5 mL), N-
bromosuccinimide (116 mg, 0.65 mmol) and DMF (7 µL) were added. The 
reaction mixture was stirred at room temperature for 1 h. The mixture was 
quenched with Na2S2O3 saturated solution and extracted with dichloromethane. The organic layer 
was washed with brine, dried over Na2SO4, filtered and the solvent concentrated under vacuum. The 
crude was purified by flash column chromatography (SiO2, hexane/ethyl acetate 98:2) to yield ethyl 
2-bromo-4H-furo[3,2-b]indole-4-carboxylate (159 mg, 79%) as white solid (m.p. 96-98° C). 1H NMR 
(300 MHz, CDCl3): 8.32 (bs, 1H), 7.64 (m, 1H), 7.44-7.06 (m, 2H), 6.80 (s, 1H), 4.53 (q, J = 7.1 Hz, 
2H), 1.52 (t, J = 7.1 Hz, 3H). 13C {1H} NMR (75 MHz, CDCl3): 150.8 (C), 143.4 (C), 137.6 (C), 
129.6 (C), 125.0 (C), 124.3 (CH), 123.6 (CH), 117.6 (C), 116.3 (CH), 116.2 (CH), 105.1 (CH), 63.3 
(CH2), 14.5 (CH3). Anal. Calcd for C13H10BrNO3: C, 50.67; H, 3.27; N, 4.55. Found: C, 50.49; H, 
3.28; N, 4.54.  
Ethyl 2-phenyl-4H-furo[3,2-b]indole-4-carboxylate (1k). To a N2-flushed solution of phenylboronic 
acid (67 mg 0.54 mmol), potassium carbonate (249 mg, 1.8 mmol.), PdCl2(PPh3)2 (16 mg, 0.02 mmol) 
in DMF (2 mL) and water (0.6 mL), ethyl 2-bromo-4H-furo[3,2-b]indole-4-carboxylate (140 mg 0.45 
mmol)was added. The reaction mixture was heated at reflux for 1.5 h and then cooled at room 
temperature. The mixture was diluted with water and extracted with ethyl acetate. The organic layer 
was washed with brine, dried over Na2SO4, filtered and the solvent concentrated under vacuum. The 
crude was purified by flash column chromatography (SiO2, hexane/ethyl acetate 98:2) to yield 1k 
(105 mg, 76%) as white solid (m.p. 114-116° C). 1H NMR (300 MHz, CDCl3): 8.32 (bs, 1H), 7.81 
(dd, J = 5.2, 3.3 Hz, 2H), 7.69 (m, 1H), 7.48-7.38 (m, 2H), 7.38-7.21 (m, 3H), 7.06 (bs, 1H), 4.55 (q, 
J = 7.1 Hz, 2H), 1.54 (t, J = 7.1 Hz, 3H). 13C {1H} NMR (75 MHz, CDCl3): 157.3 (C), 151.1 (C), 
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142.9 (C), 138.5 (C), 131.1 (C), 128.8 (2xCH), 127.8 (CH), 123.9 (CH), 123.8 (2xCH), 123.5 (CH), 
118.0 (C), 116.31 (CH), 116.29 (CH), 97.8 (CH), 63.1 (CH2), 14.5 (CH3). One quaternary carbon is 
missing, probably overlapped. ESI(+)-MS: m/z(%) = 306 (100) [M+H]+. Anal. Calcd for C19H15NO3: 
C, 74.74; H, 4.95; N, 4.59. Found: C, 74.86; H, 4.97; N, 4.58.  
General Procedure for the Synthesis of Compounds 4a-m. To a N2-flushed solution of ethyl 2-
methyl-4H-furo[3,2-b]indole-4-carboxylate 1b-e, 1h-k (1 equiv.) and [IPrAu(NTf2)] (5 mol%) in 
anhydrous dichloromethane, a solution of N-allenamide 2a-g (1.2 equiv.) in dichloromethane was 
added dropwise at -20° C. The reaction mixture was stirred for the stated time at -20° C and then 
quenched with PPh3 (15 mol%). The solvent was removed under vacuum and the crude residue was 
purified by flash column chromatography to yield the desired product 4a-m. 
(E)-ethyl 3-methyl-3'-oxo-5-((2-oxooxazolidin-3-yl)methylene)spiro[cyclopent[2]ene-1,2'-indoline]-
1'-carboxylate (4a). General procedure was followed using ethyl 2-methyl-4H-furo[3,2-b]indole-4-
carboxylate 1b (49 mg, 0.2 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-one 2a (30 mg, 0.24 mmol) 
and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 1 h. 
Purification by flash chromatography (SiO2, hexane/ethyl acetate 1:1) yielded 4a (50 mg, 68%) as a 
yellowish wax. 1H NMR (300 MHz, C6D6): 8.46 (bs, 1H), 7.81 (d, J = 7.6 Hz, 1H), 7.30 (m, 1H, 
overlapping with the signal of C6D6), 6.79 (t, J = 7.4 Hz, 1H), 6.44 (s, 1H), 4.95 (s, 1H), 4.16 (q, J = 
7.1 Hz, 2H), 3.35 (m, 2H), 3.18 (m, 2H), 2.85 (m, 1H), 2.73 (m, 1H), 1.78 (s, 3H), 1.05 (t, J = 7.1 Hz, 
3H). 13C{1H} NMR (75 MHz, C6D6): 198.0 (C), 155.4 (C), 153.0 (C), 151.6 (C), 145.4 (C), 137.1 
(CH), 124.6 (CH), 123.4 (CH), 123.3 (CH), 122.3 (C), 118.5 (CH), 116.8 (CH), 82.8 (C) 61.6 (CH2), 
61.2 (CH2), 43.4 (CH2), 40.0 (CH2), 16.5 (CH3), 14.0 (CH3). One quaternary carbon is missing, 
probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 489 (100) [M+Na]
+. Anal. Calcd for 
C20H20N2O5: C, 65.21; H, 5.47; N, 7.60. Found: C, 65.29; H,.5.46: N, 7.59. 
(E)-ethyl-3-methyl-3'-oxo-5-((2-oxopyrrolidin-1-yl)methylene)spiro[cyclopent[2]ene-1,2'-indoline]-
1'-carboxylate (4b). General procedure was followed using ethyl 2-methyl-4H-furo[3,2-b]indole-4-
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carboxylate 1b (49 mg, 0.2 mmol), 1-(propa-1,2-dien-1-yl)pyrrolidin-2-one 2b (37 mg, 0.3 mmol) 
and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 3 h. 
Purification by flash chromatography (SiO2, hexane/ethyl acetate 2:1) yielded 4b (45 mg, 61%) as 
yellowish wax. 1H NMR (300 MHz, C6D6): 8.50 (bs, 1H), 7.79 (dd, J = 7.6, 0.7 Hz, 1H), 7.32 (m, 
1H), 6.93 - 6.67 (m, 2H), 4.99 (s, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.41 - 3.20 (m, 2H), 3.10 (m, 1H), 
2.97 (m, 1H), 1.93 - 1.81 (m, 2H), 1.78 (s, 3H), 1.21 - 1.11 (m, 2H), 1.03 (t, J = 7.1 Hz, 3H). 13C{1H} 
NMR (75 MHz, C6D6): 198.1 (C), 172.3 (C), 153.1 (C), 151.6 (C), 145.5 (C), 137.0 (CH), 124.6 
(CH), 123.3 (CH), 123.3 (CH), 122.4 (C), 118.3 (CH), 116.8 (CH), 83.1 (C), 61.4 (CH2), 46.2 (CH2), 
40.6 (CH2), 29.6 (CH2), 17.4 (CH2), 16.5 (CH3), 14.0 (CH3). One quaternary carbon is missing, 
probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 367 (100) [M+H]
+. Anal. Calcd for 
C21H22N2O4: C, 68.84; H, 6.05; N, 7.65. Found: C, 69.03; H, 6.04; N, 7.66. 
(E)-ethyl-5-((N,4-dimethylphenylsulfonamido)methylene)-3-methyl-3'-oxospiro[cyclopent[2]ene-
1,2'-indoline]-1'-carboxylate (4c). General procedure was followed using ethyl 2-methyl-4H-
furo[3,2-b]indole-4-carboxylate 1b (49 mg, 0.2 mmol), N,4-dimethyl-N-(propa-1,2-dien-1-
yl)benzenesulfonamide 2c (53 mg, 0.24 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous 
dichloromethane (3+1 mL) at -20° C for 3 h. Purification by flash chromatography (SiO2, 
hexane/ethyl acetate 9:1) yielded 4c (72 mg, 77%) as yellowish wax. 1H NMR (300 MHz, C6D6): 
8.69 (bs, 1H), 7.79 (d, J = 7.6 Hz, 1H), 7.72 (d, J = 8.1 Hz, 2H), 7.29 (m, 1H, overlapping with the 
signal of C6D6), 6.91 (d, J = 8.1 Hz, 2H), 6.77 (t, J = 7.4 Hz, 1H), 5.62 (bs, 1H), 4.87 (s, 1H), 4.25 
(q, J = 7.1 Hz, 2H), 3.54 - 3.24 (m, 2H), 2.55 (s, 3H), 1.93 (s, 3H), 1.63 (s, 3H), 1.09 (t, J = 7.1 Hz, 
3H). 113C{1H} NMR (75 MHz, C6D6): 197.2 (C), 153.3 (C), 151.9 (C), 146.2 (C), 143.1 (C), 137.0 
(CH), 134.4 (C), 129.5 (2xCH), 127.6 (2xCH), 124.4 (CH), 123.3 (CH), 122.5 (CH), 122.4 (CH), 
122.4 (C), 116.7 (CH), 82.0 (C), 61.9 (CH2), 40.5 (CH2), 36.2 (CH3), 20.8 (CH3), 16.3 (CH3), 13.8 
(CH3). One quaternary carbon is missing, probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 
489 (100) [M+Na]+. Anal. Calcd for C25H26N2O5S: C, 64.36; H, 5.62; N, 6.00. Found: C, 64.18; H, 
5.63; N, 5.99. 
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(E)-ethyl 3-methyl-5-((4-methyl-N-phenylphenylsulfonamido)methylene)-3'-
oxospiro[cyclopent[2]ene-1,2'-indoline]-1'-carboxylate (4d). General procedure was followed using 
ethyl 2-methyl-4H-furo[3,2-b]indole-4-carboxylate 1b (49 mg, 0.2 mmol), 4-methyl-N-phenyl-N-
(propa-1,2-dien-1-yl)benzenesulfonamide 2d (69 mg, 0.24 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 
mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 18 h. Purification by flash 
chromatography (SiO2, hexane/ethyl acetate 9:1) yielded 4d (52 mg, 49%) as yellowish oil. 
1H NMR 
(300 MHz, C6D6): 8.75 (bs, 1H), 7.81 (d, J = 7.6 Hz, 1H), 7.52 (d, J = 8.2 Hz, 2H), 7.39 - 7.20 (m, 
3H, overlapped with the signal of C6D6), 7.10 - 6.91 (m, 3H), 6.79 (dd, J = 12.3, 4.7 Hz, 2H), 6.65 
(d, J = 8.1 Hz, 2H), 4.83 (d, J = 1.4 Hz, 1H), 4.26 - 4.12 (m, 2H), 2.93 - 2-63 (m, 2H), 1.84 (s, 3H), 
1.45 (s, 3H), 1.03 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, C6D6): 197.3 (C), 153.4 (C), 151.9 
(C), 145.6 (C), 143.2 (C), 140.1 (C), 137.1 (CH), 135.8 (C), 129.4 (2xCH), 128.8 (2xCH), 128.1 
(CH), 127.6 (2xCH), 127.0 (2xCH), 124.6 (CH), 123.3 (CH), 122.8 (CH), 122.2 (C), 122.0 (CH), 
116.9 (CH), 82.2 (C), 61.8 (CH2), 40.1 (CH2), 20.8 (CH3), 16.1 (CH3), 13.8 (CH3). One quaternary 
carbon is missing, probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 551 (100) [M+Na]
+. Anal. 
Calcd for C30H28N2O5S: C, 68.16; H, 5.34; N, 5.30. Found: C, 68.07; H, 5.33; N, 5.29. 
(E)-ethyl 5-((N-benzyl-4-methylphenylsulfonamido)methylene)-3-methyl-3'-
oxospiro[cyclopent[2]ene-1,2'-indoline]-1'-carboxylate (4e). General procedure was followed using 
ethyl 2-methyl-4H-furo[3,2-b]indole-4-carboxylate 1b (49 mg, 0.2 mmol), N-benzyl-4-methyl-N-
(propa-1,2-dien-1-yl)benzenesulfonamide 2e (72 mg, 0.24 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 
mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 18 h. Purification by flash 
chromatography (SiO2, hexane/ethyl acetate 9:1 to 8:2) yielded 4e (67 mg, 62%) as white thick wax. 
1H NMR (300 MHz, C6D6): 8.73 (d, J = 7.9 Hz, 1H), 7.81 (d, J = 8.3 Hz, 3H), 7.33 - 7.19 (m, 4H, 
overlapped with the signal of C6D6), 7.17 - 7.06 (m, 2H), 6.96 (d, J = 8.2 Hz, 2H), 6.76 (t, J = 7.4 Hz, 
1H), 5.21 (s, 1H), 4.77 (d, J = 1.5 Hz, 1H), 4.22 (dq, J = 10.4, 7.1 Hz, 1H), 4.05 (d, J = 13.9 Hz, 1H), 
3.98- 3.81 (m, 2H), 3.51 - 3.23 (m, 2H), 1.95 (s, 3H), 1.51 (s, 3H), 0.95 (t, J = 7.1 Hz, 3H). 13C{1H} 
NMR (75 MHz, C6D6): 196.5 (C), 153.4 (C), 151.9 (C), 146.5 (C), 143.1 (C), 136.9 (CH), 136.5 (C), 
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135.5 (C), 129.5 (2xCH), 128.9 (2xCH), 128.5 (2xCH), 127.7 (3xCH), 124.3 (CH), 123.2 (CH), 122.4 
(C), 121.9 (CH), 120.8 (CH), 116.7 (CH), 111.1 (C), 81.6 (C), 61.9 (CH2), 54.5 (CH2), 40.7 (CH2), 
20.8 (CH3), 16.1 (CH3), 13.5 (CH3). ESI(+)-MS: m/z (%) = 543 (100) [M+H]
+. Anal. Calcd for 
C31H30N2O5S: C, 68.61; H, 5.57; N, 5.16. Found: C, 68.73; H, 5.56; N, 5.17. 
(E)-ethyl 5-((benzyl(tert-butoxycarbonyl)amino)methylene)-3-methyl-3'-oxospiro[cyclopent[2]ene-
1,2'-indoline]-1'-carboxylate (4f). To a N2-flushed solution of ethyl 2-methyl-4H-furo[3,2-b]indole-
4-carboxylate 1b (49 mg, 0.2 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in 3 mL of anhydrous 
dichloromethane, a solution of tert-butyl benzyl(propa-1,2-dien-1-yl)carbamate 2f (45 mg, 0.2 mmol) 
in 1 mL of dichloromethane was added dropwise at -20° C. The reaction mixture was stirred for 1 h. 
Then another solution of tert-butyl benzyl(propa-1,2-dien-1-yl)carbamate 2f (45 mg, 0.2 mmol) in 1 
mL of dichloromethane was added dropwise at -20° C. The reaction was stirred for 1 h, then quenched 
with PPh3 and the solvent was removed under vacuum. Purification by flash chromatography (SiO2, 
hexane/ethyl acetate 9:1 to 8:2) yielded 4f (70 mg, 72%) as yellow thick wax. 1H NMR (300 MHz, 
C6D6): 8.67 (bs, 1H), 7.81 (dd, J = 7.6, 0.7 Hz, 1H), 7.39 - 7.03 (m, 6H, overlapping with the signal 
of C6D6), 6.78 (t, J = 7.2 Hz, 1H), 6.60 (bs, 1H), 4.92 (d, J = 1.4 Hz, 1H), 4.67 (bs, 2H), 4.23 - 3.91 
(m, 2H), 3.28 - 2.94 (m, 2H), 1.61 (d, J = 0.9 Hz, 3H), 1.36 (s, 9H), 0.93 (t, J = 7.0 Hz, 3H). 13C{1H} 
NMR (75 MHz, C6D6): 197.6 (C), 153.3 (C), 151.8 (C), 145.4 (C), 139.1 (C), 136.8 (CH), 128.4 
(2xCH), 127.0 (3xCH), 124.5 (CH), 123.1 (CH), 123.0 (CH), 122.6 (CH), 122.5 (C), 116.7 (CH), 
80.4 (C), 61.3 (CH2), 49.4 (CH2), 40.2 (CH2), 29.9 (C) 27.8 (3xCH3), 16.3 (CH3), 13.8 (CH3). Two 
quaternary carbons are missing, probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 511 (100) 
[M+Na]+. Anal. Calcd for C29H32N2O5: C, 71.29; H, 6.60; N, 5.73. Found: C, 71.47; H, 6.61; N, 5.72. 
(E)-ethyl 3,5'-dimethyl-3'-oxo-5-((2-oxooxazolidin-3-yl)methylene)spiro[cyclopent[2]ene-1,2'-
indoline]-1'-carboxylate (4g). General procedure was followed using ethyl 2,7-dimethyl-4H-
furo[3,2-b]indole-4-carboxylate 1c (52 mg, 0.2 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-one 2a 
(38 mg, 0.3 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous dichloromethane (3+1 mL) 
at -20° C for 1 h. Purification by flash chromatography (SiO2, hexane/ethyl acetate 3:1 to 1:1) yielded 
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4g (43 mg, 56%) as yellowish wax. 1H NMR (300 MHz, C6D6): 8.42 (bs, 1H), 7.63 (s, 1H), 7.15 (dd, 
J = 8.7, 1.7 Hz, 1H), 6.50 (s, 1H), 5.01 (s, 1H), 4.18 (q, J = 7.1 Hz, 2H), 3.39 - 3.25 (m, 2H), 3.2 - 
3.08 (m, 2H), 2.90 - 2.78 (m, 1H), 2.75 - 2.64 (m, 1H), 2.02 (s, 3H), 1.80 (s, 3H), 1.07 (t, J = 7.1 Hz, 
3H). 13C{1H} NMR (75 MHz, C6D6): 198.1 (C), 155.4 (C), 151.6 (C), 151.2 (C), 145.2 (C), 138.3 
(CH), 133.1 (C), 124.5 (CH), 123.5 (CH), 122.4 (C), 118.4 (CH), 116.6 (CH), 83.0 (C), 61.5 (CH2), 
61.2 (CH2), 43.4 (CH2), 40.0 (CH2), 20.1 (CH3), 16.5 (CH3), 14.0 (CH3). One quaternary carbon is 
missing, probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 405 (100) [M+Na]
+. Anal. Calcd 
for C21H22N2O5: C, 65.96; H, 5.80; N, 7.33. Found: C, 65.84; H, 5.79; N, 7.34. 
(E)-ethyl 5-((N-benzyl-4-methylphenylsulfonamido)methylene)-3,5'-dimethyl-3'-
oxospiro[cyclopent[2]ene-1,2'-indoline]-1'-carboxylate (4h). To a N2-flushed solution of ethyl 2,7-
dimethyl-4H-furo[3,2-b]indole-4-carboxylate 1c (52 mg, 0.2 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 
mmol) in 3 mL of anhydrous dichloromethane, a solution of N-benzyl-4-methyl-N-(propa-1,2-dien-
1-yl)benzenesulfonamide 2e (90 mg, 0.30 mmol) in 1 mL of dichloromethane was added dropwise in 
12 h with the syringe pump at -20° C. The reaction mixture was stirred for 18 h. Then the reaction 
was quenched with PPh3 and the solvent was removed under vacuum. Purification by flash 
chromatography (SiO2, hexane/ethyl acetate 9:1 to 8:2) yielded 4h (65 mg, 60%) as yellow thick oil. 
1H NMR (300 MHz, C6D6): 8.53 (bs, 1H), 7.67 (d, J = 8.2 Hz, 2H), 7.48 (s, 1H), 7.21 - 7.04 (m, 4H 
overlapping with the signal of C6D6), 7.04 - 6.92 (m, 2H), 6.83 (d, J = 8.1 Hz, 2H), 5.10 (s, 1H), 4.67 
(d, J = 1.5 Hz, 1H), 4.09 (dq, J = 10.4, 7.1 Hz, 1H), 3.95 (d, J = 13.9 Hz, 1H), 3.89 - 3.70 (m, 2H), 
3.35 - 3.10 (m, 2H), 1.85 (s, 3H), 1.80 (s, 3H), 1.38 (d, J = 1.0 Hz, 3H), 0.82 (t, J = 7.1 Hz, 3H). 
13C{1H} NMR (75 MHz, C6D6): 196.3 (C), 151.7 (C), 151.4 (C), 146.1 (C), 142.9 (C), 137.8 (CH), 
136.4 (C), 135.5 (C), 132.7 (C), 129.4 (2xCH), 128.7 (2xCH), 128.3 (2xCH), 127.5 (2xCH), 127.5 
(CH), 124.0 (CH), 122.4 (C), 122.0 (CH), 120.6 (CH), 116.3 (CH), 81.7 (C), 61.6 (CH2), 54.4 (CH2), 
40.5 (CH2), 20.6 (CH3), 19.9 (CH3), 16.0 (CH3), 13.3 (CH3). One quaternary carbon is missing, 
probably overlapping with C6D6. ESI(+)-MS: m/z (%) = 579 (100) [M+Na]
+. Anal. Calcd for 
C32H32N2O5S: C, 69.04; H, 5.79; N, 5.03. Found: C, 68.97; H, 5.80; N, 5.04. 
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(E)-ethyl 5'-methoxy-3-methyl-3'-oxo-5-((2-oxooxazolidin-3-yl)methylene)spiro[cyclopent[2]ene-
1,2'-indoline]-1'-carboxylate (4i). General procedure was followed using ethyl 7-methoxy-2-methyl-
4H-furo[3,2-b]indole-4-carboxylate 1e (55 mg, 0.2 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-one 
2a (38 mg, 0.3 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous dichloromethane (3+1 
mL) at -20° C for 3 h. Purification by flash chromatography (SiO2, hexane/ethyl acetate 1:1) yielded 
4i (35 mg, 44%) as yellowish wax. 1H NMR (300 MHz, C6D6): 8.32 (bs, 1H), 7.14 (d, J = 2.8 Hz, 
1H), 7.01 (dd, J = 9.1, 2.9 Hz, 1H), 6.45 (bs, 1H), 4.89 (bs, 1H), 4.01 (q, J = 7.1 Hz, 2H), 3.15-2.92 
(m, 7H), 2.64 (m, 1H), 2.47 (m, 1H), 1.65 (s, 3H), 0.89 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, 
C6D6): 198.1 (C), 156.5 (C), 155.3 (C), 151.4 (C), 147.7 (C), 144.7 (C), 126.3 (CH), 124.0 (C), 123.5 
(CH), 122.8 (C), 118.4 (CH), 118.0 (CH), 105.2 (CH), 83.1 (C), 61.3 (CH2), 60.9 (CH2), 54.7 (CH3), 
43.1 (CH2), 39.9 (CH2), 16.4 (CH3), 13.9 (CH3). ESI(+)-MS: m/z (%) = 399 (100) [M+H]
+. Anal. 
Calcd for C21H22N2O6: C, 63.31; H, 5.57; N, 7.03. Found: C, 62.91; H, 5.58; N, 7,05.  
(E)-ethyl 5-((N-benzyl-4-methylphenylsulfonamido)methylene)-5'-fluoro-3-methyl-3'-
oxospiro[cyclopent[2]ene-1,2'-indoline]-1'-carboxylate (4j). General procedure was followed using 
ethyl 7-fluoro-2-dimethyl-4H-furo[3,2-b]indole-4-carboxylate 1d (52 mg, 0.2 mmol), N-benzyl-4-
methyl-N-(propa-1,2-dien-1-yl)benzenesulfonamide 2e (90 mg, 0.3 mmol) [IPrAu(NTf2)] (8.7 mg, 
0.01 mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 18 h. Purification by flash 
chromatography (SiO2, hexane/ethyl acetate 9:1 to 8:2) yielded 4j (55 mg, 45%) as yellow thick oil. 
1H NMR (300 MHz, C6D6): 8.51 (bs, 1H), 7.77 (d, J = 8.2 Hz, 2H), 7.41 (dd, J = 6.8, 2.8 Hz, 1H), 
7.31 - 7.19 (m, 4H), 7.12 (m, 1H), 7.00 - 6.87 (m, 3H), 5.19 (s, 1H), 4.76 (d, J = 1.5 Hz, 1H), 4.26 - 
3.80 (m, 4H), 3.46 - 3.22 (m, 2H), 1.96 (s, 3H), 1.52 (d, J = 0.9 Hz, 3H), 0.94 (t, J = 7.1 Hz, 3H). 
13C{1H} NMR (75 MHz, C6D6): 195.8 (C), 158.9 (d, J = 245 Hz, C), 151.8 (C), 149.6 (C), 146.8 (C), 
143.2 (C), 136.4 (C), 135.4 (C), 129.6 (2xCH), 128.8 (2xCH), 128.5 (2xCH), 127.7 (CH), 127.6 
(2xCH), 124.1 (d, J = 24.0 Hz, CH), 123.3 (d, J = 7.0 Hz, C), 121.6 (CH), 120.9 (CH), 118.0 (d, J = 
7.2 Hz, CH), 111.1 (C), 109.6 (d, J = 22.9 Hz, CH), 82.1 (C), 62.0 (CH2), 54.5 (CH2), 40.6 (CH2), 
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20.8 (CH3), 16.1 (CH3), 13.5 (CH3). ESI(+)-MS: m/z (%) = 561 (100) [M+H]
+; Anal. Calcd for 
C31H29FN2O5S: C, 66.41; H, 5.21; N, 5.00. Found: C, 66.31; H, 5.20; N, 4.99. 
(E)-ethyl-6'-fluoro-3-methyl-3'-oxo-5-((2-oxooxazolidin-3-yl)methylene)spiro[cyclopentane-1,2'-
indolin]-2-ene-1'-carboxylate (4k). General procedure was followed using ethyl 6-fluoro-2-methyl-
4H-furo[3,2-b]indole-4-carboxylate 1h (52.2 mg, 0.2 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-
one 2a (38 mg, 0.3 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in anhydrous dichloromethane 
(3+1 mL) at -20° C for 3 h. Purification by flash chromatography (SiO2, hexane/ethyl acetate 1:1) 
yielded 4k (40 mg, 52%) as white wax. 1H NMR (300 MHz, CDCl3): 7.85 (bs, 1H), 7.74 (dd, J = 8.5, 
5.8 Hz, 1H), 6.89 (td, J = 8.5, 2.2 Hz, 1H), 6.17 (t, J = 2.1 Hz, 1H), 5.16 (d, J = 1.5 Hz, 1H), 4.39 (t, 
J = 8.0 Hz, 2H), 4.28 (m, 2H), 4.08 (m, 2H), 3.44 (s, 2H), 1.94 (s, 3H), 1.31 (m, 3H). 13C{1H} NMR  
(75 MHz, CDCl3): 197.2 (C), 169.0 (d, J = 257 Hz, C), 156.0 (C), 151.3 (C), 146.7 (C), 145.3 (C), 
127.1 (d, J = 12.2 Hz, CH), 122.9 (C), 122.4 (CH), 118.9 (CH), 118.3 (C), 111.9 1 (d, J = 25.2 Hz, 
CH) , 104.5 1 (d, J = 28 Hz, CH), 83.5 (C), 62.3 (CH2), 62.1 (CH2), 44.2 (CH2), 40.0 (CH2), 16.9 
(CH3), 14.3 (CH3). ESI(+)-MS: m/z (%) = 387 (100) [M+H]
+; Anal. Calcd for C20H19FN2O5: C, 62.17; 
H, 4.96; N, 7.25. Found: C, 62.33; H, 4.94; N, 7.23.  
(E)-ethyl-5-(((N-benzyl-4-methylphenyl)sulfonamido)methylene)-6'-fluoro-3-methyl-3'-
oxospiro[cyclopentane-1,2'-indolin]-2-ene-1'-carboxylate (4l). General procedure was followed 
using ethyl 6-fluoro-2-dimethyl-4H-furo[3,2-b]indole-4-carboxylate 1h (52 mg, 0.2 mmol), N-
benzyl-4-methyl-N-(propa-1,2-dien-1-yl)benzenesulfonamide 2e (90 mg, 0.3 mmol) [IPrAu(NTf2)] 
(8.7 mg, 0.01 mmol) in anhydrous dichloromethane (3+1 mL) at -20° C for 24 h. Purification by flash 
chromatography (SiO2, hexane/ethyl acetate 9:1 to 8:2) yielded 4l (73 mg, 65%) as yellow thick oil. 
1H NMR (300 MHz, CDCl3):7.94 (d, J = 9.9 Hz, 1H), 7.71 (dd, J = 8.5, 5.7 Hz, 1H), 7.55 (d, J = 8.3 
Hz, 2H), 7.40 – 7.11 (m, 7H), 6.86 (td, J = 8.5, 2.2 Hz, 1H), 5.04 (d, J = 1.5 Hz, 2H), 4.27 – 4.04 (m, 
3H), 3.74 (bs, 1H), 3.26 – 2.97 (m, 2H), 2.39 (s, 3H), 1.81 (d, J = 1.2 Hz, 3H), 1.04 (t, J = 6.9 Hz, 
3H). 13C{1H} NMR (75 MHz, CDCl3): 195.5 (C), 168.8 (d, J = 257 Hz, C), 154.7 (d, J = 14.1 Hz, 
C), 151.5 (C), 147.32 (C), 143.74 (C), 135.88 (C), 134.54 (C), 129.7 (2xCH), 128.47 (2xCH), 128.37 
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(2xCH), 127.78 (CH), 127.33 (2xCH), 126.62 (d, J = 11.8 Hz, CH), 121.29 (CH), 120.70 (CH), 
118.21 (C), 111.58 (d, J = 24.4 Hz, CH), 104.14 (d, J = 29.2 Hz, CH), 82.20 (C), 62.26 (CH2), 54.08 
(CH2), 40.34 (CH2), 21.49 (CH3), 16.73 (CH3), 13.64 (CH3). One quaternary carbon is missing, 
probably overlapped. ESI(+)-MS: m/z (%) = 561 (100) [M+H]+. Anal. Calcd for C31H29FN2O5S: C, 
66.41; H, 5.21; N, 5.00. Found: C, 66.52; H, 5.21; N, 4.38.  
Ethyl (R,E)-5-(((R)-4-benzyl-2-oxooxazolidin-3-yl)methylene)-3-methyl-3'-oxospiro[cyclopentane-
1,2'-indolin]-2-ene-1'-carboxylate (4m). To a N2-flushed solution of 2-methyl-4H-furo[3,2-b]indole-
4-carboxylate 1b (49 mg, 0.2 mmol) and [IPrAu(NTf2)] (8.7 mg, 0.01 mmol) in 3 mL of anhydrous 
dichloromethane, a solution of (R)-4-benzyl-3-(2l5-propa-1,2-dien-1-yl)oxazolidin-2-one 2g (65 mg, 
0.3 mmol) in 1 mL of dichloromethane was added dropwise in 12 h with the syringe pump at -20° C. 
The reaction mixture was stirred for 18 h. Then the reaction was quenched with PPh3 and the solvent 
was removed under vacuum. Purification by flash chromatography (SiO2, toluene/ethyl acetate 3:1) 
yielded 4m (45 mg, 49%, dr = 13:1) as clear thick oil. Given data refers to major isomer. 1H NMR 
(500 MHz, CDCl3): 7.88 (dt, J = 8.2, 0.8 Hz, 1H), 7.39-7.24 (m, 4 H), 7.23-7.16 (m, 2H), 7.12 -7.06 
(m, 2H), 6.12 (t, J = 1.5 Hz, 1H), 5.21 (m, 1H), 4.46 (q, J = 7.1 Hz, 2H), 3.72 (dd, J = 8.6, 3.4 Hz, 
1H), 3.62 (m, 1H), 3.51 (m, 1H), 3.44 (m, 1H), 3.33 (dd, J = 20.2, 1.0 Hz, 1H), 2.98 (dd, J = 13.4, 
4.0 Hz, 1H), 2.38 (m, 1H), 1.95 (d, J = 1.3 Hz, 3H), 1.45 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (125 
MHz, CDCl3): 174.9 (C), 155.8 (C), 150.8 (C), 144.3 (C), 140.8 (C), 138.7 (C), 135.5 (C), 129.7 (C), 
129.1 (2xCH), 128.84 (2xCH), 128.76 (CH), 127.1 (CH), 126.2 (CH), 125.0 (CH), 124.6 (CH), 118.2 
(CH), 114.8 (CH), 66.2 (CH2), 64.1 (C), 63.5 (CH2), 58.9 (CH), 43.0 (CH2), 37.5 (CH2), 16.6 (CH3), 
14.2 (CH3). ESI(+)-MS: m/z(%) = 459 (100) [M+H]
+; Anal. Calcd for C27H26N2O5: C, 70.73; H, 5.72; 
N, 6.11. Found: C, 70.94; H, 5.71; N, 6.09.  
General Procedure for the Synthesis of Compounds 3a-f. To a N2-flushed solution of appropriate 
ethyl 4H-furo[3,2-b]indole-4-carboxylate 1a,f,g (1.2 equiv.) and (ArO)3PAu(NTf2) (5 mol%) in 
anhydrous toluene and in the presence of 200 mg of 4 Å MS, a solution of the appropriate N-
allenamide 2a-d (1.0 equiv.) in toluene was added dropwise at -20 °C. The reaction mixture was 
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stirred for 15 minutes, quenched with PPh3 (15 mol%) and filtered through a pad of celite. The crude 
was purified by flash chromatography to yield the corresponding hydroarylated product 3a-f. 
(E)-ethyl 2-(3-(2-oxooxazolidin-3-yl)allyl)-4H-furo[3,2-b]indole-4-carboxylate (3a). General 
procedure was followed using ethyl 4H-furo[3,2-b]indole-4-carboxylate 1a (55 mg, 0.24 mmol), 3-
(propa-1,2-dien-1-yl)oxazolidin-2-one 2a (25 mg, 0.2 mmol), (ArO)3PAu(NTf2) (11 mg, 0.05 mmol) 
in anhydrous toluene (3+1 mL) at -20° C. Purification by flash chromatography (SiO2, hexane/ethyl 
acetate 2:1) yielded 3a (64 mg, 90%), as a pink solid (m.p. 139.5-141° C). 1H NMR (300 MHz, 
CD2Cl2): 8.31 (bs, 1H), 7.64 (m, 1H), 7.37 - 7.21 (m, 2H), 6.88 (d, J = 14.2 Hz, 1H), 6.58 (s, 1H), 
5.07 (dt, J = 14.2, 7.1 Hz, 1H), 4.56 - 4.34 (m, 4H), 3.79 - 3.65 (m, 2H), 3.63 (d, J = 7.1 Hz, 2H), 
1.52 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, CD2Cl2): 158.5 (C), 155.2 (C), 151.0 (C), 141.9 
(C), 138.0 (C), 130.2 (C), 126.3 (CH), 123.3 (CH), 123.2 (CH), 118.0 (C), 116.1 (CH), 115.7 (CH), 
105.5 (CH), 99.2 (CH), 63.1 (CH2), 62.3 (CH2), 42.5 (CH2), 29.8 (CH2), 14.2 (CH3). EI-MS: m/z(%) 
= 354 (100) [M]+. Anal. Calcd for C19H18N2O5: C, 64.40; H, 5.12; N, 7.91. Found: C, 64.63; H, 5.13; 
N, 7.92. 
(E)-ethyl 2-(3-(2-oxopyrrolidin-1-yl)allyl)-4H-furo[3,2-b]indole-4-carboxylate (3b). General 
procedure was followed using ethyl 4H-furo[3,2-b]indole-4-carboxylate 1a (55 mg, 0.24 mmol), 1-
(propa-1,2-dien-1-yl)pyrrolidin-2-one 2b (25 mg, 0.2 mmol), (ArO)3PAu(NTf2) (11 mg, 0.05 mmol) 
in anhydrous toluene (3+1 mL) at -20° C. Purification by flash chromatography (SiO2, hexane/ethyl 
acetate 2:1) yielded 3b (58 mg, 80%), as a pink solid (m.p. 141.4-142.9° C). 1H NMR (300 MHz, 
CD2Cl2): 8.31 (bs, 1H), 7.63 (m, 1H), 7.35 - 7.26 (m, 2H), 7.09 (d, J = 14.4 Hz, 1H), 6.57 (s, 1H), 
5.17 (dt, J = 14.3, 7.1 Hz, 1H), 4.53 (q, J = 7.1 Hz, 2H), 3.63 (d, J = 7.1 Hz, 2H), 3.55 (dd, J = 8.8, 
5.6 Hz, 2H), 2.47 (t, J = 8.1 Hz, 2H), 2.18 - 2.06 (m, 2H), 1.52 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 
MHz, CD2Cl2): 172.9 (C), 158.9 (C), 151.0 (C), 141.9 (C), 138.0 (C), 130.3 (C), 126.0 (CH), 123.2 
(2xCH), 118.1 (C), 116.1 (CH), 115.7 (CH), 106.1 (CH), 99.2 (CH), 63.1 (CH2), 45.2 (CH2), 31.1 
(CH2), 30.2 (CH2), 17.5 (CH2), 14.2 (CH3). ESI(+)-MS: m/z(%) = 576 (100) [M+Na]
+. Anal. Calcd 
for C20H20N2O4: C, 65.96; H, 5.80; N, 7.33. Found: C, 65.84; H, 5.79; N, 7.34. 
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(E)-ethyl 2-(3-(N,4-dimethylphenylsulfonamido)allyl)-4H-furo[3,2-b]indole-4-carboxylate (3c). 
General procedure was followed using ethyl 4H-furo[3,2-b]indole-4-carboxylate 1a (55 mg, 0.24 
mmol), N,4-dimethyl-N-(propa-1,2-dien-1-yl)benzenesulfonamide 2c (45 mg, 0.2 mmol), 
(ArO)3PAu(NTf2) (11 mg, 0.05 mmol) in anhydrous toluene (6+4 mL) at -20° C. The reaction mixture 
was stirred for 1 h. Purification by flash chromatography (SiO2, hexane/ethyl acetate 95:5) yielded 
3c (66 mg, 61%), as a wax. 1H NMR (300 MHz, CD2Cl2): 8.31 (bs, 1H), 7.73 - 7.60 (m, 3H), 7.39-
7.27 (m, 4H), 6.99 (d, J = 14.0 Hz, 1H), 6.52 (s, 1H), 4.96 (dt, J = 14.1, 7.1 Hz, 1H), 4.53 (q, J = 7.1 
Hz, 2H), 3.58 (d, J = 7.1 Hz, 2H), 2.91 (s, 3H), 2.44 (s, 3H), 1.52 (t, J = 7.1 Hz, 3H). 13C{1H} NMR 
(75 MHz, CD2Cl2): 158.7 (C), 151.0 (C), 144.1 (C), 141.9 (C), 137.9 (C), 134.5 (C), 130.3 (CH), 
129.7 (2xCH), 127.0 (2xCH), 123.3 (CH), 123.2 (CH), 118.0 (C), 116.2 (CH), 115.6 (CH), 105.9 
(CH), 99.1 (CH), 63.1 (CH2), 32.3 (CH3), 29.7 (CH2), 21.2 (CH3), 14.2 (CH3). One quaternary carbon 
is missing, probably overlapped. ESI(+)-MS: m/z(%) = 453 (100) [M+H]+. Anal. Calcd for 
C24H24N2O5S: C, 63.70; H, 5.35; N, 6.19. Found: C, 63.62; H, 5.36; N, 6.18. 
(E)-ethyl-2-(3-(4-methyl-N-phenylphenylsulfonamido)allyl)-4H-furo[3,2-b]indole-4-carboxylate 
(3d). General procedure was followed using ethyl 4H-furo[3,2-b]indole-4-carboxylate 1a (55 mg, 
0.24 mmol), 4-methyl-N-phenyl-N-(propa-1,2-dien-1-yl)benzenesulfonamide 2d (57 mg, 0.2 mmol), 
(ArO)3PAu(NTf2) (11 mg, 0.05 mmol) in anhydrous toluene (6+4 mL) at -20° C. The reaction mixture 
was stirred for 1 h. Purification by flash chromatography (SiO2, hexane/ethyl acetate 95:5) yielded 
3d (62 mg, 60%), as a pink solid (m.p. 148.5-151°C). 1H NMR (300 MHz, CD2Cl2): 8.27 (bs, 1H), 
7.62-7.54 (m, 3H), 7.43 - 7.24 (m, 7H), 7.18 (dt, J = 13.9, 1.2 Hz, 1H), 7.08 - 6.95 (m, 2H), 6.40 (s, 
1H), 4.63 - 4.42 (m, 3H), 3.49 (d, J = 7.2 Hz, 2H), 2.45 (s, 3H), 1.48 (t, J = 7.1 Hz, 3H). 13C{1H} 
NMR (75 MHz, CD2Cl2): 158.4 (C), 151.0 (C), 144.1 (C), 141.8 (C), 137.9 (C), 136.7 (C), 135.8 (C), 
131.3 (CH), 130.1 (2xCH), 129.6 (2xCH), 129.4 (2xCH), 128.9 (CH), 127.4 (2xCH), 123.2 (CH), 
123.2 (CH), 118.0 (C), 116.1 (CH), 115.6 (CH), 107.0 (CH), 99.1 (CH), 63.0 (CH2), 29.7 (CH2), 21.3 
(CH3), 14.2 (CH3). One quaternary carbon is missing, probably overlapped. ESI(+)-MS: m/z(%) = 
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537 (100) [M+Na]+. Anal. Calcd for C29H26N2O5S: C, 67.69; H, 5.09; N, 5.44. Found: C, 67.53; H, 
5.08; N, 5.45. 
(E)-ethyl 7-methyl-2-(3-(2-oxooxazolidin-3-yl)allyl)-4H-furo[3,2-b]indole-4-carboxylate (3e). 
General procedure was followed using ethyl 7-methyl-4H-furo[3,2-b]indole-4-carboxylate 1f (58 mg, 
0.24 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-one 2a (25 mg, 0.2 mmol), (ArO)3PAu(NTf2) (11 
mg, 0.05 mmol) in anhydrous toluene (3+1 mL) at -20° C. Purification by flash chromatography 
(SiO2, hexane/ethyl acetate 2:1) yielded 3e (52 mg, 70%), as a pink solid (m.p. 121.2-122.7° C). 
1H 
NMR (300 MHz, CD2Cl2): 8.17 (bs, 1H), 7.43 (s, 1H), 7.12 (dd, J = 8.5, 1.1 Hz, 1H).), 6.87 (d, J = 
14.2 Hz, 1H), 6.56 (s, 1H), 5.06 (dt, J = 14.2, 7.1 Hz, 1H), 4.56 - 4.41 (m, 4H), 3.75 (dd, J = 8.9, 7.2 
Hz, 2H), 3.62 (d, J = 7.1 Hz, 2H), 2.49 (s, 3H), 1.51 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, 
CD2Cl2): 158.3 (C), 155.2 (C), 151.0 (C), 141.8 (C), 136.2 (C), 133.0 (C), 126.2 (CH), 124.4 (CH), 
118.1 (C), 115.7 (2xCH), 105.5 (CH), 99.2 (CH), 62.9 (CH2), 62.3 (CH2), 42.5 (CH2), 29.8 (CH2), 
21.0 (CH3), 14.2 (CH3). One quaternary carbon is missing, probably overlapped. ESI(+)-MS: m/z(%) 
= 391 (100) [M+Na]+. Anal. Calcd for C20H20N2O5: C, 65.21; H, 5.47; N, 7.60. Found: C, 65.33; H, 
5.49; N, 7.58. 
(E)-ethyl 7-fluoro-2-(3-(2-oxooxazolidin-3-yl)allyl)-4H-furo[3,2-b]indole-4-carboxylate (3f). 
General procedure was followed using ethyl 7-fluoro-4H-furo[3,2-b]indole-4-carboxylate 1g (59 mg, 
0.24 mmol), 3-(propa-1,2-dien-1-yl)oxazolidin-2-one 2a (25 mg, 0.2 mmol), (ArO)3PAu(NTf2) (11 
mg, 0.05 mmol) in anhydrous toluene (3+1 mL) at -20° C. Purification by flash chromatography 
(SiO2, hexane/ethyl acetate 4:1) yielded 3f (71 mg, 95%), as a pink solid (m.p. 172.6-173.1° C). 
1H 
NMR (300 MHz, CD2Cl2): 8.24 (s, 1H), 7.28 (m, 1H), 6.99 (td, J = 9.2, 2.7 Hz, 1H), 6.85 (d, J = 14.3 
Hz, 1H), 6.54 (s, 1H), 5.03 (dt, J = 14.2, 7.1 Hz, 1H), 4.54 - 4.39 (m, 4H), 3.73 (dd, J = 8.9, 7.2 Hz, 
2H), 3.64 - 3.57 (m, 2H), 1.49 (t, J = 7.1 Hz, 3H). 13C{1H} NMR (75 MHz, CD2Cl2): 159.5 (d, J = 
239 Hz, C). 159.4 (C), 155.2 (C), 150.8 (C), 145.9 (C),134.2 (C), 126.4 (CH), 118.6 (d, J = 10.8 Hz, 
C), 117.1 (d, J = 9.4 Hz, CH), 110.2 (d, J = 24.9 Hz, CH), 105.2 (CH), 101.8 (d, J = 26.0 Hz, CH), 
99.2 (CH), 63.2 (CH2), 62.3 (CH2), 42.5 (CH2), 29.8 (CH2), 14.2 (CH3). One quaternary carbon is 
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missing, probably overlapped. ESI(+)-MS: m/z(%) = 395 (100) [M+Na]+. Anal. Calcd for 
C19H17FN2O5: C, 61.29; H, 4.60; N, 7.52. Found: C, 61.24; H, 4.59; N, 7.53. 
Preparation of products 5a, 5b and 6. 
(Z)-N-((1'-(ethoxycarbonyl)-3-methyl-3'-oxospiro[cyclopentane-1,2'-indoline]-2,4-dien-5-
yl)methylene)-1-phenylmethanaminium hydroxide (5a). To solution of 4f (62 mg, 0.13 mmol) in 
dichloromethane (1 ml) TFA (0.1 ml) was added dropwise at room temperature and the resulting 
mixture was stirred for 1 h at room temperature. Then it was quenched with 1M NaOH solution (10 
ml) and extracted with dichloromethane (3 x 10 ml). Purification by flash chromatography (SiO2, 
hexane/ethyl acetate 9:1) yielded 5a (20 mg, 38%) as yellow thick oil. 1H NMR (300 MHz, CDCl3): 
12.65 (bs, 1H), 8.66 (s, 1H), 8.20 (d, J = 8.2 Hz, 1H), 7.61 (d, J = 13.4 Hz, 1H), 7.55 (m, 1H), 7.49-
7.34 (m, 6H), 7.08 (t, J = 7.3 Hz, 1H), 6.88 (s, 1H), 6.79 (s, 1H), 4.76 (d, J = 5.7 Hz, 2H), 4.20 (q, J 
= 7.1 Hz, 2H), 2.13 (s, 3H), 1.32 (m, 3H). 13C{1H} NMR (75 MHz, CDCl3): 189.4 (C), 153.8 (C), 
153.3 (CH), 141.2 (CH), 137.2 (C), 136.3 (C), 135.1 (CH), 130.8 (CH), 130.7 (2 x CH), 130.6 (C), 
129.1 (2 x CH), 129.3 (C), 128.2 (CH), 127.5 (CH), 125.7 (C), 121.4 (CH), 120.1 (CH), 117.7 (C), 
61.02 (CH2), 53.35 (CH2), 14.60 (CH3), 14.23 (CH3). ESI(+)-MS: m/z (%) = 411 (100) [M+Na]
+.  
(5b): To solution of 4h (50 mg, 0.09 mmol) in dichloromethane (1 ml) TFA (0.1 ml) was added 
dropwise at room temperature and the resulting mixture was stirred for 5 h at room temperature. Then 
it was quenched with 1M NaOH solution (10 ml) and extracted with dichloromethane (3 x 10 ml). 
Purification by flash chromatography (SiO2, toluene/ethyl acetate 98:2) yielded 5b (16 mg, 31%) as 
yellow thick oil. 1H NMR (300 MHz, CDCl3): 9.55 (s, 1H), 9.05 (s, 1H), 8.15 (d, J = 8.5 Hz, 1H), 
7.81 (d, J = 8.4 Hz, 2H), 7.41 (d, J = 1.7 Hz, 1H), 7.35-7.20 (m, 8H), 6.61 (d, J = 1.5 Hz, 1H), 6.22 
(s, 1H), 5.10 (s, 2H), 4.21 (q, J = 7.1 Hz, 2H), 2.43 (s, 3H), 2.31 (s, 3H), 1.92 (s, 3H), 1.33 (t, J = 7.1 
Hz, 3H). 13C{1H} NMR (75 MHz, CDCl3): 193.8 (C), 154.0 (C), 145.2 (C), 142.7 (CH), 139.9 (C), 
139.7 (CH), 136.7 (C), 135.4 (C), 134.9 (C), 134.2 (C), 133.1 (CH), 132.0 (CH), 130.5 (C), 130.2 (2 
x CH), 128.9 (2 x CH), 127.7 (2 x CH), 127.6 (CH), 127.1 (C), 126.1 (2 x CH), 121.7 (CH), 120.4 
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(C), 120.0 (CH), 61.0 (CH2), 51.5 (CH2), 21.6 (CH3), 20.7 (CH3), 15.06 (CH3)., 14.57 (CH3). ESI(+)-
MS: m/z (%) = 579 (100) [M+Na]+.  
2-hydroxy-5'-methyl-3'-oxospiro[cyclopentane-1,2'-indoline]-2,4-diene-3,5-dicarbaldehyde (6). To 
a suspension of 4g (43 mg, 0.1 mmol) in 1,4-dioxane (0.4 ml) SeO2 (27 mg, 0.25 mmol) was added 
and the mixture was stirred at 100 °C for 2.5 h. Then it was filtered over a pad of celite and 
concentrated in vacuum. Purification by flash chromatography (SiO2hexane/ethyl acetate 3:1) yielded 
6 (7 mg, 25%) as yellow thick oil. 1H NMR (500 MHz, DMSO): 13.38 (s, 1H), 9.93 (s, 1H), 9.34 (s, 
1H), 8.29 (m, 2H), 8.10 (s, 1H), 7.72 (d, J = 7.6 Hz, 1H), 2.53 (s, 3H). 13C{1H} NMR (125 MHz, 
DMSO): 185.3 (CH), 185.2 (CH), 160.8 (C), 144.4 (CH), 143.9 (C), 137.0 (C), 134.6 (CH), 134.2 
(C), 122.7 (CH), 119.8 (CH), 118.9 (C), 116.5 (C), 115.8 (C), 113.4 (C) 21.33 (CH3). ESI(-)-MS: 
m/z (%) = 252 (100) [M-OH]-. 
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